10-Q

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

0001193125-22-015993.txt : 20220124 0001193125-22-015993.hdr.sgml : 20220124 20220124155318 ACCESSION NUMBER: 0001193125-22-015993 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20220124 DATE AS OF CHANGE: 20220124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Forbion European Acquisition Corp. CENTRAL INDEX KEY: 0001874495 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41148 FILM NUMBER: 22549220 BUSINESS ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KYL-1104 BUSINESS PHONE: 31356993020 MAIL ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KYL-1104 10-Q 1 d250880d10q.htm 10-Q 10-Q

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

FORBION EUROPEAN ACQUISITION CORP.

(Exact Name of Registrant as Specified in its Charter)


Cayman Islands	001-41148	N/A
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


4001 Kennett Pike, Suite 302 Wilmington, Delaware 19807		19807
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +1 302 273 0765

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A ordinary shares, par value $0.0001 per share	FRBN	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	FRBNW	The Nasdaq Stock Market LLC
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant	FRBNU	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act):

Yes

☒ No ☐

As of January 24, 2022, there were 12,650,000 shares of the Class A ordinary shares, $0.0001 par value, and 3,162,500 shares of Class B ordinary shares $0.0001 par value, issued and outstanding.

Table of Contents

FORBION EUROPEAN ACQUISITION CORP.

TABLE OF CONTENTS


		Page
Part I. Financial Information			3
Item 1.	Financial Statements		3
	Condensed Balance Sheet as of September 30, 2021 (unaudited)		3
	Condensed Statements of Operations for the period from August 9, 2021 (inception) through September 30, 2021 (unaudited)		4
	Condensed Statement of Changes in Shareholder’s Equity for the period from August 9, 2021 (inception) through September 30, 2021 (unaudited)		5
	Condensed Statement of Cash Flows for the period from August 9, 2021 (inception) through September 30, 2021 (unaudited)		6
	Notes to Condensed Financial Statements (unaudited)		7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		20
Item 3.	Quantitative and Qualitative Disclosures Regarding Market Risk		23
Item 4.	Controls and Procedures		23
Part II. Other Information			24
Item 1.	Legal Proceedings		24
Item 1A.	Risk Factors		24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		24
Item 3.	Defaults Upon Senior Securities		24
Item 4.	Mine Safety Disclosures		24
Item 5.	Other Information		24
Item 6.	Exhibits		24
Part III. Signatures			25

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

FORBION EUROPEAN ACQUISITION CORP.

UNAUDITED CONDENSED BALANCE SHEET


	September 30, 2021
	(unaudited)
Assets:
Deferred offering costs	$	354,615

Total assets	$	354,615

Liabilities and Shareholder’s Equity
Accrued offering costs and expenses	$	340,356

Total current liabilities		340,356

Commitments and Contingencies (Note 6)
Shareholder’s Equity:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding		—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding		—
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 3,162,500 shares issued and outstanding (1)		316
Additional paid-in capital		24,684
Accumulated deficit		(10,741	)

Total shareholder’s equity		14,259

Total Liabilities and Shareholder’s Equity	$	354,615

(1)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FORBION EUROPEAN ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS


	For the period from August 9, 2021 (inception) through September 30, 2021
Formation costs	$	10,741

Net loss	$	(10,741	)

Basic and diluted weighted average Class B ordinary shares outstanding (1)		2,750,000

Basic and diluted net loss per share	$	(0.00	)

(1)

This number excludes an aggregate of up to 412,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Notes 5 and 8). On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend (see Note 8).

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FORBION EUROPEAN ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER’S EQUITY

FOR THE PERIOD FROM AUGUST 9, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021


	Class B				Additional					Total
	Ordinary Shares				Paid-in		Accumulated			Shareholder’s
	Shares (1)		Amount		Capital		Deficit			Equity
Balance as of August 9, 2021 (inception)		—	$	—	$	—	$	—		$	—
Class B ordinary shares issued to Sponsor		3,162,500		316		24,684		—			25,000
Net loss		—		—		—		(10,741	)		(10,741	)

Balance as of September 30, 2021 (unaudited)		3,162,500	$	316	$	24,684	$	(10,741	)	$	14,259

(1)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FORBION EUROPEAN ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM AUGUST 9, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021


Cash flows from operating activities:
Net loss	$	(10,741	)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation cost paid by Sponsor		6,941
Changes in operating assets and liabilities:
Accrued expenses		3,800

Net cash used in operating activities		—

Net change in cash	$	—
Cash, August 9, 2021 (inception)	$	—

Cash, end of the period	$	—

Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	$	18,059

Deferred offering costs included in accrued offerings costs and expenses	$	336,556

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

FORBION EUROPEAN ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED UNAUDITED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

Note 1 — Organization, Business Operation and Liquidity

Forbion European Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on August 9, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar

business combination with one or more businesses or entities (the “Business Combination”).

As of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 9, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate

non-operating

income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering (the “IPO”). The Company has selected December 31 as its fiscal year end.

The Company’s Sponsor is Forbion Growth Sponsor FEAC I B.V., a Cayman Islands limited liability company (the “Sponsor”).

The registration statement for the Company’s the IPO was declared effective on December 9, 2021 (the “Effective Date”). On December 14, 2021, the Company’s consummated the IPO of 11,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share and

one-third

of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8).

Simultaneously with the consummation of the IPO and full exercise of the overallotment, the Company consummated the private placement of 5,195,000 warrants (the “Private Placement Warrants”) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement

Warrants

in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8).

Transaction costs related to the IPO amounted to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $907,500 in transaction costs for aggregate transaction costs of $6,510,013 consisting of $2,130,000 of underwriting commissions, $3,727,500 of deferred underwriting commissions and $652,513 of other offering costs (see Note 8). In addition, $1,641,236 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50%

or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

Table of Contents

This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500

deposit in advance

from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act

having a maturity of 185 days

or less or in money market funds meeting certain conditions under Rule

2a-7

redeem 100% of

the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, and (c) the redemption of the public shares if the Company has not consummated the Company’s Business Combination within the Combination Period, subject to applicable law. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The funds held in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of its public shareholders. As it is expected that we are and will continuously be considered a Dutch tax resident, any redemption proceeds (including interest income on the trust account) distributed to our shareholders in excess of the

paid-up

capital for Dutch tax purposes may be subject

to 15% Dutch dividend withholding tax.

The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account is initially

anticipated to be $10.25 per public share.

The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close.

Table of Contents

The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least

$5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company’s amended and restated memorandum and articles of association provides that the Company will have only 18 months from the closing of the

IPO

(or up to 24 months

from the closing of this offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

$100,000

of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

The Sponsor and each member of its management team have entered into an agreement with Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (ii) to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

The Company has until 18 months

from the closing of the IPO to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within the Combination Period. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account, for each additional three-month period

, $1,265,000 ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline.

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.25

per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations.

Table of Contents

Liquidity and Capital Resources

Prior to the completion of the IPO, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. The Company has since completed its IPO at which time capital in excess of the funds deposited in the trust and used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since

re-evaluated

the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year form the date the financial statements are issued and therefore substantial doubt has been alleviated.

Risks and Uncertainties

Management is currently evaluating the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and Article 8 of Regulation

S-X

of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus, which contains the initial audited financial statements and notes thereto for the period from August 9, 2021 (inception) to August 13, 2021 as filed with the SEC on December 13, 2021, and the Company’s report on Form

8-K,

which contains the Company’s audited balance sheet and notes thereto as of December 14, 2021, as filed with the SEC on December 21, 2021. The interim results for the three months ended September 30, 2021 and for the period from August 9, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Table of Contents

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.

Offering Costs associated with the IPO

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC

340-10-S99-1.

Offering costs are allocated ratably with the redeemable and

non-redeemable

shares they are allocated to. Upon

initial

closing of the IPO on December 14, 2021, offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to shareholders’ equity. The Company incurred offering costs amounting to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 11,000,000 Class A ordinary shares subject to possible redemption (12,650,000 Class A ordinary shares subject to possible redemption following the full exercise of the underwriters’ over-allotment option on December 15, 2021) are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Table of Contents

Net Loss Per Share

Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 412,500 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters (see Note 5). At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under Financial Accounting Standards Board (“FASB”) ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)

2020-06,

Debt—Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. ASU

2020-06

is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU

2020-06

would have on its financial position, results of operations or cash flows.

Table of Contents

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3 — IPO

On December 14, 2021, the Company consummated its IPO of 11,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one Class A ordinary share and

one-third

of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8).

Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500

deposit in advance from

the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

under the Investment Company Act which invest only in direct U.S. government treasury obligations.

Note 4 — Private Placement

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 4,700,000 Private Placement Warrants (5,195,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Unit. The sale of the Private Placement

arrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8).

The Private Placement Warrants are not be transferable, assignable or salable (and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants are not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination), except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Warrants.”

If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the

IPO

. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants require a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

Note 5 — Related Party Transactions

Founder Shares

On August 12, 2021, Forbion European Sponsor LLP paid $25,000, or approximately $0.009 per share, to cover certain offering costs in consideration for 2,875,000 Class B ordinary shares (the “Founder Shares”), par value $0.0001. On November 23, 2021, Forbion European Sponsor LLP transferred 2,875,000 Class B ordinary shares to the Sponsor in exchange for $25,000, or approximately $0.009 per share. On December 9, 2021, the Company issued 287,500 Class B ordinary shares to the Sponsor resulting from a 1.1 for 1 share dividend. Up to 412,500 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands.

Table of Contents

Promissory Note — Related Party

On August 12, 2021, Forbion European Sponsor LLP agreed to loan the Company up to $500,000 to be used for a portion of the expenses of the

IPO

. These loans are

non

-interest

bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of the

IPO

. The loan will be repaid out of the offering proceeds not held in the Trust Account and is now due on demand.

Working Capital Loans

In order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close. The Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans.

Related Party Extension Loans

The Company may extend the period of time to consummate a Business Combination by up to two additional three-month periods (for a total of 24 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the trust account, for each additional three-month period, $1,265,000, ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. Any such payments would be made in the form of a

non-interest

bearing, unsecured promissory note. Such notes would either be paid upon consummation of a Business Combination, or, at the relevant insider’s discretion, converted upon consummation of a Business Combination into additional Private Placement Warrants at a price of $1.50 per Private Warrant. The Sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for the Company to complete a Business Combination.

Office Space, Secretarial and Administrative Services

Commencing on December 9, 2021, the date that the Company’s securities are first listed on the NASDAQ through the earlier of

the

consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support and to reimburse the Sponsor for any

out-of-pocket

expenses related to identifying, investigating and completing an initial Business Combination.

Additionally, the Sponsor has agreed to pay an annual salary of $25,000 to each of the independent Board Members for services rendered prior to or in connection with the completion of the Business Combination. Board members are entitled to reimbursement for any

out-of-pocket

expenses related to identifying, investigating, negotiating and completing the Business Combination as well.

Note 6 — Commitments & Contingencies

Registration and Shareholder Rights

The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and extension loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants

Table of Contents

that may be issued upon conversion of Working Capital Loans and extension loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the

IPO

. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, as described in the following paragraph, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Except as described herein, the Sponsor and the Company’s directors and executive officers have agreed not to transfer, assign or sell (i) their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company complete a liquidation, merger, share exchange or other similar transaction that results in all of its

ublic

hareholders having the right to exchange their ordinary shares for cash, securities or other property, and (ii) any of their Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of the initial Business Combination. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor with respect to any Founder Shares, Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof. The Company refer to such transfer restrictions throughout this prospectus as the

lock-up.

In addition, pursuant to the registration and shareholder rights agreement, the Sponsor, upon and following consummation of an initial Business Combination, will be entitled to nominate three individuals for appointment to the Company’s board of directors, as long as the

ponsor holds any securities covered by the registration and shareholder rights agreement. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands.

Underwriting Agreement

The underwriters

were granted

45-day

option from the date of the IPO to purchase up to an additional 1,650,000 Units to cover over-allotments, if any. On December 15, 2021, the underwriters fully exercised the over-allotment option (see Note 8).

The underwriters were paid underwriting commission of $0.20 per Unit sold in the IPO, excluding Units sold to the

anchor investor

, or $1,800,000, upon the closing of the IPO. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $330,000 for an aggregate of $2,130,000 in underwriting commissions related to the IPO and over-allotment (see Note 8).

In addition, $3,150,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO, excluding those Units sold to the

anchor investor

. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $577,500 for an aggregate of $3,727,500 in deferred underwriting commissions related to the IPO and over-allotment (see Note 8). The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Forward Purchase Agreements

The Company has entered into two forward purchase agreements with an affiliate of the Sponsor (the “FPA Purchaser”), pursuant to which the FPA Purchaser has agreed to purchase (1) an aggregate of 1,000,000 Class A ordinary shares for $10.00 per share (the “firm forward purchase shares”), or an aggregate amount of $10,000,000 and (2) in addition, an aggregate of up to 1,000,000 Class A ordinary shares for $10.00 per share (the “additional forward purchase shares”), or an aggregate maximum amount of up to $10,000,000, in each case in a private placement that may close simultaneously with the closing of the Company’s initial Business Combination.

Table of Contents

Note 7 — Shareholder’s Equity

Preference shares

— The

Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September, 2021, there were no preference shares issued or outstanding.

Class

A ordinary shares

— The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021, there were no Class A ordinary shares outstanding.

Class

B ordinary shares

— The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of August 13, 2021, there were 2,875,000 Class B ordinary shares issued and outstanding. Of the 2,875,000 Class B ordinary shares, an aggregate of up to 375,000 shares are subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part. On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding, of which 412,500 are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. All share and per share amounts have been retroactively restated to reflect the share dividend. The forfeiture amounts were determined such that the initial shareholders will collectively own 20%

of the Company’s issued and outstanding ordinary shares after the

IPO

. As of September 30, 2021, there were 3,162,500 Class B ordinary shares outstanding.

Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act (As Revised) of the Cayman Islands or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by the Company’s shareholders

. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least

two-thirds

of the Company’s ordinary shares that are voted, and pursuant to the Company’s amended and restated memorandum and articles of association; such actions include amending the Company’s amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. The Company’s board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed in each year. There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment of directors can appoint all of the directors. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. The Company’s shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.

The Class B ordinary shares and will automatically convert into Class A ordinary shares, which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions if

he Company does not consummate an initial Business Combination, at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares equal, in the aggregate, on an

as-converted

basis, 20%

of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of its management team upon conversion of Working Capital Loans and extension loans. Any conversion of Class B ordinary shares described herein will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less

than

one-to-one.

Table of Contents

Public Warrants

– Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described adjacent to “Redemption of public warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value.

Redemption of public warrants

. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption, which the Company refer to as the

“30-day

redemption period”; and

•

if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Redemption Procedures—Anti-dilution Adjustments”) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company send the notice of redemption to the warrant holders.

Table of Contents

The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the

30-day

redemption period. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants —Public Shareholders’ Warrants—Redemption Procedures—Anti-dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

If the Company calls the Public Warrants for redemption as described above, it will have the option to require any holder that wishes to exercise its public warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their public warrants on a “cashless basis,” the Company will consider, among other factors, its cash position, the number of public warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of Class A ordinary shares issuable upon the exercise of the Public Warrants. If the Company takes advantage of this option, all holders of Public Warrants would pay the exercise price by surrendering their public warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the

10-day

average closing price as of the date on which the notice of redemption is sent to the holders of the warrants. If the Company takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Class A ordinary shares to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. The Company believes this feature is an attractive option if it does not need the cash from the exercise of the warrants after the Business Combination. If the Company calls the warrants for redemption and does not take advantage of this option, the Sponsor and its permitted transferees would still be entitled to exercise their private placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below.

No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if the Company is not the surviving company in the Business Combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

Note 8 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. Based upon this evaluation, the Company did not identify any other subsequent events that would have required adjustments or disclosure in the financial statements, other than those disclosed below:

On December

9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend.

On December 14, 2021, Company’s commenced the IPO of 11,000,000 units (or 12,650,000 units if the underwriters’ over-allotment option is exercised in full) at $10.00 per unit. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000.

Table of Contents

Simultaneously with the consummation of th

IPO, the Company consummated the private placement of 4,700,000 warrants (or 5,195,000 warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500.

In connection with the IPO, the Company entered into the following agreements:

•

An Underwriting Agreement, dated December 9, 2021, between the Company, UBS Securities LLC and Kempen & Co. USA, Inc. (the “

Underwriting Agreement

”).

•

The Amended and Restated Memorandum and Articles of Association of the Company, dated December 9, 2021.

•

A Warrant Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

•

A Letter Agreement, dated December 9, 2021, between the Company and its officers, directors and the Sponsor.

•

An Investment Management Trust Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.

•

A Registration and Shareholder Rights Agreement, dated December 9, 2021, among the Company and the Sponsor.

•

An Administrative Services Agreement, dated December 9, 2021, between the Company and the Sponsor.

•

A Private Placement Warrants Purchase Agreement, dated December 9, 2021, between the Company and the Sponsor.

•

Indemnity Agreements, each dated December 9, 2021, between the Company and each of its executive officers and directors.

•

A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V.

•

A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to Forbion European Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated on August 9, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”).

Our sponsor is Forbion Growth Sponsor FEAC I B.V., a Cayman Islands limited liability company (the “Sponsor”). The registration statement for our IPO was declared effective on December 9, 2021. On December 14, 2021, we commenced our IPO of 11,000,000 units (or 12,650,000 units if the underwriters’ over-allotment option is exercised in full) at $10.00 per unit. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. Transaction costs related to the IPO amounted to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs

Simultaneously with the consummation of the IPO, we consummated the private placement of 4,700,000 warrants (or 5,195,000 warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500

Upon the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500 deposit in advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay income taxes, if any, our amended and restated memorandum and articles of association, as discussed below and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to us, until the completion of the initial Business Combination, or (2) to the Public Shareholders, until the earliest of (a) the completion of the initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the limitations described herein, (b) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if we do not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, and (c) the redemption of the Public Shares if we have not consummated our Business Combination within the Combination Period, subject to applicable law. Public Shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if we have not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The funds held in the Trust Account could become subject to the claims of our creditors, if any, which could have priority over the claims of the Public Shareholders. As it is expected that we are and will continuously be considered a Dutch tax resident, any redemption proceeds (including interest income on the trust account) distributed to our shareholders in excess of the

paid-up

capital for Dutch tax purposes may be subject to 15% Dutch dividend withholding tax.

Table of Contents

Our amended and restated memorandum and articles of association provides that we will have only 18 months from the closing of the IPO (or up to 24 months from the closing of this offering if we extend the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate the initial Business Combination. If we have not consummated an initial Business Combination within the Combination Period, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate an initial Business Combination within the Combination Period.

Liquidity and Capital Resources

Until the consummation of the IPO, our only source of liquidity was an initial purchase of Class B ordinary shares, par value $0.0001 (the “Class B ordinary shares”), by the Sponsor and loans from our Sponsor.

As of September 30, 2021, we had no cash and had deferred offering costs of $354,615. Further, we expect to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to complete our initial Business Combination will be successful.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our initial Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, we did not have any outstanding working capital loans.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our initial Business Combination or redeem a significant number of our Public Shares upon completion of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Results of Operations

As of September 30, 2021, we had not commenced any operations. All activity for the period from August 9, 2021 (inception) through September 30, 2021 relates to our formation and the IPO. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We will generate

non-operating

income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the period from August 9, 2021 (inception) to September 30, 2021, we had net loss of $10,741, which consisted of formation costs.

Table of Contents

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.

Office Space, Secretarial and Administrative Services

Commencing on December 9, 2021, the date that our securities are first listed on the NASDAQ, through the earlier of the consummation of the initial Business Combination and the liquidation, we agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support and to reimburse the Sponsor for any

out-of-pocket

expenses related to identifying, investigating and completing an initial Business Combination.

out-of-pocket

expenses related to identifying, investigating, negotiating and completing the Business Combination as well.

Underwriting Agreement

The underwriters were granted a

45-day

option from the date of the IPO to purchase up to an additional 1,650,000 Units to cover over-allotments, if any. On December 15, 2021, the underwriters fully exercised the over-allotment option.

The underwriters were paid underwriting commission of $0.20 per Unit sold in the IPO, excluding Units sold to the anchor investor, or $1,800,000, upon the closing of the IPO. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $330,000 for an aggregate of $2,130,000 in underwriting commissions related to the IPO and over-allotment.

In addition, $3,150,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO, excluding those Units sold to the anchor investor. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $577,500 for an aggregate of $3,727,500 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Forward Purchase Agreements

We have entered into two forward purchase agreements with an affiliate of the Sponsor (the “FPA Purchaser”), pursuant to which the FPA Purchaser has agreed to purchase (1) an aggregate of 1,000,000 Class A ordinary shares for $10.00 per share (the “firm forward purchase shares”), or an aggregate amount of $10,000,000 and (2) in addition, an aggregate of up to 1,000,000 Class A ordinary shares for $10.00 per share (the “additional forward purchase shares”), or an aggregate maximum amount of up to $10,000,000, in each case in a private placement that may close simultaneously with the closing of the Company’s initial Business Combination.

Table of Contents

Critical Accounting Policies

Offering Costs associated with the IPO

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. We comply with the requirements of the ASC

340-10-S99-1.

Offering costs are allocated ratably with the redeemable and

non-redeemable

shares they are allocated to. Upon initial closing of the IPO on December 14, 2021, offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to shareholders’ equity. We incurred offering costs amounting to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs.

Ordinary Shares Subject to Possible Redemption

We account for ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, 11,000,000 Class A ordinary shares subject to possible redemption (12,650,000 Class A ordinary shares subject to possible redemption following the full exercise of the underwriters’ over-allotment option on December 15, 2021) are presented at redemption value as temporary equity, outside of the shareholders’ equity section of our balance sheet.

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Net Loss Per Share

Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 412,500 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. At September 30, 2021, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements

Off-Balance Sheet Arrangements

As of September 30, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation

S-K.

Inflation

We do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.

Emerging Growth Company Status

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, us, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred from August 9, 2021 (inception) through September 30, 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our final prospectus for our IPO filed with the SEC. As of the date of this Report, there have been no material changes to the risk factors disclosed in our final prospectus for our IPO filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On August 12, 2021, we issued 2,875,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”) to our Sponsor for $25,000, or approximately $0.012 per share, to cover certain offering costs in connection with our formation. Such shares were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

On December 14, 2021 the Company consummated the sale of 11,000,000 Units, (or 12,650,000 Units if the underwriters’ over-allotment option is exercised in full) at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 4,700,000 warrants (or 5,195,000 warrants if the underwriters’ over-allotment option is exercised in full) at a price of $1.50 per warrant (the “Private Placement Warrants”), for an aggregate purchase price of $7,050,000, or $7,792,500 if the underwriters’ over-allotment option is exercised in full. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Following the initial closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a U.S.-based trust account with J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500 deposit in advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was placed in the Trust Account.

On December 15, 2021, the underwriters exercised their full over-allotment option, resulting in an additional 1,650,000 Units issued for gross proceeds of $16,500,000.

Transaction costs associated with the underwriters’ exercise of their over-allotment option amounted to $907,500 of underwriting fees, $330,000 in underwriting discount paid at the time of the over-allotment and $577,500 in deferred underwriting fees. A total of $16,912,500 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $129,662,500.

There has been no material change in the planned use of the proceeds from the IPO and the private placement as is described in the final prospectus included in the IPO Registration Statement.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form

10-Q.


No.		Description of Exhibit

31.1		Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2		Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101.INS		Inline XBRL Instance Document*

101.SCH		Inline XBRL Taxonomy Extension Schema Document*

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document*

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document*

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

*	Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EX-31.1 2 d250880dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jasper Bos, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the period from August 9 (inception) through September 30, 2021 of Forbion European Acquisition Corp. (the “registrant”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the unaudited condensed financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-31.2 3 d250880dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Cyril Lesser, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the period from August 9 (inception) through September 30, 2021 of Forbion European Acquisition Corp. (the “registrant”);

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-32.1 4 d250880dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Forbion European Acquisition Corp. (the “Company”) on Form 10-Q for the period from August 9 (inception) through September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jasper Bos, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: January 24, 2022


/s/ Jasper Bos
Name:		Jasper Bos
Title:		Chief Executive Officer

EX-32.2 5 d250880dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Forbion European Acquisition Corp. (the “Company”) on Form 10-Q for the period from August 9 (inception) through September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Cyril Lesser, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: January 24, 2022

/s/ Cyril Lesser

Name: Cyril Lesser

Title: Chief Financial Officer

EX-101.SCH 6 frbn-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheet link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheet (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements Of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements Of Operations (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statement Of Changes In Shareholder's Equity link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statement Of Changes In Shareholder's Equity (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Condensed Statement Of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Organization, Business Operation and Liquidity link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - IPO link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Shareholder's Equity link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Organization, Business Operation and Liquidity - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - IPO - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Private Placement - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Commitments & Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Shareholder's Equity - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 frbn-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 frbn-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 frbn-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Common Class A [Member] Common Class B [Member] Common Class B [Member] Document Information [Line Items] Document Type Document Period End Date Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Current Fiscal Year End Date Document Quarterly Report Document Transition Report Entity Interactive Data Current Entity Current Reporting Status Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity File Number Entity Filer Category Entity Shell Company Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Security Exchange Name Entity Common Stock, Shares Outstanding Title of 12(b) Security Trading Symbol Entity Central Index Key Equity Components [Axis] Equity Component [Domain] Capital Units [Member] Redeemable Warrants [Member] Redeemable Warrants. Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Assets [Abstract] Assets: Deferred Offering Costs Deferred offering costs Assets Total assets Stockholders' Equity Attributable to Parent [Abstract] Shareholder's Equity: Preferred Stock, Value, Issued Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding Common Stock, Value, Issued Common stock Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total shareholder's equity Balance Balance Liabilities and Equity Total Liabilities and Shareholder's Equity Liabilities and Equity [Abstract] Liabilities and Shareholder's Equity Commitments and Contingencies Commitments and Contingencies (Note 6) Liabilities, Current Total current liabilities Accrued Offering Costs and Expenses Accrued offering costs and expenses Accrued offering costs and expenses. Sale of Stock [Axis] Sale of Stock [Domain] Over-Allotment Option [Member] Over-Allotment Option [Member] Founder Shares [Member] Founder shares [Member] Founder Shares [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Subsequent Event [Member] Preferred Stock, Par or Stated Value Per Share Preferred stock par or stated value per share Preferred Stock, Shares Authorized Preferred stock shares authorized Preferred Stock, Shares Issued Preferred stock shares issued Preferred Stock, Shares Outstanding Preferred stock shares outstanding Common Stock, Par or Stated Value Per Share Common stock par or stated value per share Common stock par or stated value per share Common shares subject to forfeiture Common shares subject to forfeiture Common shares subject to forfeiture Common shares subject to forfeiture Common shares subject to forfeiture. Common Stock, Shares Authorized Common stock shares authorized Common Stock, Shares, Issued Common stock shares issued Common stock, Shares, Issued Common Stock, Shares, Outstanding Common stock, Shares, Outstanding Common stock shares outstanding Common stock shares outstanding Common stock, Shares, Outstanding Stockholders' Equity Note, Stock Split Stockholders' equity note, stock split Stockholders' Equity Note, Stock Split Income Statement [Abstract] Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Weighted Average Number of Shares Outstanding, Basic and Diluted Basic and diluted weighted average Class B ordinary shares outstanding Formation cost Formation costs Formation cost. Earnings Per Share, Basic and Diluted Basic and diluted net loss per share Statement of Stockholders' Equity [Abstract] Shares, Outstanding Balance, shares Balance, shares Stock Issued During Period, Value, Issued for Services Class B ordinary shares issued to Sponsor Stock issued during period, Value, Issued for services Stock Issued During Period, Shares, Issued for Services Class B ordinary shares issued to Sponsor, Shares Stock issued during period, Shares, Issued for services Retained Earnings [Member] Accumulated Deficit [Member] Additional Paid-in Capital [Member] Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Formation cost paid by Sponsor Formation cost paid by Sponsor Formation cost paid by sponsor. Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accrued Liabilities Accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash and Cash Equivalents, at Carrying Value Cash, August 9, 2021 (inception) Cash, end of the period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of cash flow information: Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares Deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares. Deferred Offering Costs Included In Accrued Offerings Costs And Expenses Deferred offering costs included in accrued offerings costs and expenses Deferred offering costs included in accrued offerings costs and expenses Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Operations [Text Block] Organization, Business Operation and Liquidity Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies Equity [Abstract] Disclosure Of Initial Public Offering [Text Block] IPO Disclosure of initial public offering. Private Placement [Abstract] Private Placement Abstract. Disclosure Of Private Placement [Text Block] Private Placement Disclosure of Private Placement. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments & Contingencies Stockholders' Equity Note Disclosure [Text Block] Shareholder's Equity Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Offering Costs Associated With Initial Public Offering [Policy Text Block] Offering Costs associated with the IPO Offering costs associated with initial public offering. Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Temporary Equity Policy [Policy Text Block] Ordinary Shares Subject to Possible Redemption Temporary equity policy. Income Tax, Policy [Policy Text Block] Income Taxes Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Use of Estimates, Policy [Policy Text Block] Use of Estimates Emerging Growth Company [Policy Text Block] Emerging Growth Company Status Emerging growth company. Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Organization Consolidation And Presentation Of Financial Statements [Table] Organization consolidation and presentation of financial statements. IPO [Member] IPO [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Public Warrants [Member] Public warrants. Private Placement Warrants [Member] Private placement warrants. Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization consolidation and presentation of financial statements. Entity Incorporation, Date of Incorporation Entity Incorporation Date Of Incorporation Stock Issued During Period, Shares, New Issues Stock issued during period shares new issues Stock issued during period, Shares Stock issued during period, Shares Shares Issued, Price Per Share Shares issued price per share Shares issued, Price per share Shares issued, Price per share Unit Number Of Shares Included In Unit Number of shares included in Unit Unit number of shares included in unit. Proceeds from Issuance Initial Public Offering Proceeds from issuance initial public offering Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares issued upon exercise of warrant Class of warrant or right, Number of securities called by each warrant or right Class of warrant or right, Number of securities called by each warrant or right Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Class of warrant or right, Exercise price of warrants or rights Class of warrant or right, Exercise price of warrants or rights Deferred Underwriting Commissions Deferred underwriting commissions Deferred underwriting commissions. Other Offering Costs Other Offering Costs Other offering costs. Class Of Warrant Or Right Issued During The Period Class of warrants or rights warrants issued during the period Class of warrant or right issued during the period. Class Of Warrants Or Rights Warrants Issued Issue Price Class of warrants or rights warrants issued issue price per warrant Class of warrants or rights warrants issued issue price. Proceeds from Issuance of Warrants Proceeds from private placement of warrants Proceeds from issuance of warrants Proceeds from issuance of warrants Total Offering Costs Associated With Initial Public Offering Offering costs Total offering costs associated with initial public offering. Underwriting Commissions Underwriting commissions Underwriting commissions. Additional Transaction Costs Additional transaction costs Additional transaction costs. Aggregate Transaction Costs Aggregate Transaction Costs Aggregate transaction costs. Cash Cash Fair Market Value As Percentage Of Net Assets Held In Trust Account Included In Initial Business Combination Fair market value as percentage of net assets held in trust account included in initial business combination Fair market value as percentage of net assets held in trust account included in initial business combination. Post Transaction Ownership Percentage Of The Target Entity Post-transaction ownership percentage of the target entity Post transaction ownership percentage of the target entity. Term Of Restricted Investments Term of restricted investments Term of restricted investments. Payments to Acquire Restricted Investments Investment of cash in Trust Account Payments to acquire restricted investment Cash Deposited In Trust Account Per Unit Cash deposited in Trust Account per Unit Cash deposited in trust account per unit. Additional Deposit In Advance From Related Party Deposited In Restricted Investments Additional Deposit In advance From Related Party Deposited In Restricted Investments Additional deposit in advance from related party deposited in restricted investments. Banking Regulation, Mortgage Banking, Net Worth, Minimum Minimum netorth needed to consummate business combination Percentage Of Public Shares To Be Redeemed In Case Does Not Initial Business Combination Within Combination Period Percentage of public shares to be redeemed in case does not complete initial business combination within combination period Percentage of public shares to be redeemed in case does not initial business combination within combination period. Percentage Of Dutch Dividend Withholding Tax Percentage of dutch dividend withholding tax Percentage of dutch dividend withholding tax. Redemption Value Per Share Redemption value per share. Threshold Period From The Closing Of The Public Offering To Consummate A Business Combination As Per Amended And Restated Memorandum and Articles Of Association Threshold period from the closing of public offering to consummate business combination as per amended and restated and restated articles of association Threshold period from the closing of the public offering to consummate a business combination as per amended and restated memorandum and articles of association. Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination Threshold period from the closing of the public offering extends the period of time to consummate a business combination. Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities Expenses payable on liquidation Period To Complete Business Combination From Closing of the Initial Public Offering Period To complete business combination from closing of the Initial Public Offering Period to complete business combination from closing of the initial public offering. Minimum Per Share Amount To Be Maintained In The Trust Account Minimum per share amount to be maintained in the trust account. Payments To Acquire Restricted Investment For Each Additional Three Month Period Payments to acquire restricted investment for each additional three month period Payments to acquire restricted investment for each additional three month period. Payments To Acquire Restricted Investment For Each Additional Three Month Period Per Share Payments to acquire restricted investment for each additional three month period, Per share Payments to acquire restricted investment for each additional three month period per share. Accounting Policies [Table] Accounting policies. Accounting Policies [Line Items] Accounting policies. Cash Equivalents, at Carrying Value Cash equivalents at carrying value Temporary Equity, Shares Outstanding Number of Ordinary shares subject to possible redemptions Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Weighted average number of shares common stock subject to repurchase or cancellation Weighted Average Number of Shares Outstanding, Diluted Dilutive securities Unrecognized Tax Benefits Unrecognized tax benefits Cash, FDIC Insured Amount Cash insrued with federal deposit insurance corporation Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accrued amounts for interest and penalties for unrecognized tax benefits Disclosure Of Initial Public Offering [Table] Disclosure of initial public offering. Disclosure Of Initial Public Offering [Line Items] Disclosure of initial public offering. Advance From The Sponsor Deposited In Trust Account Advance from the sponsor deposited in trust account Advance from the sponsor deposited in trust account. Common Stock, Conversion Basis Common stock, Conversion basis Proceeds From Issuance Initial Public Offering And Over Allotment Option Gross Proceeds from issuance initial public offering and over allotment option, Gross Proceeds from issuance initial public offering and over allotment option, Gross Proceeds from issuance initial public offering and over allotment option gross. Payments To Acquire Restricted Investments Per Unit Payments to acquire restricted investment, Per unit Payments to acquire restricted investments per unit. IPO And Over Allotment Option [Member] IPO And Over Allotment Option [Member] IPO And Over Allotment Option [Member] IPO And Private Placement [Member] IPO And Private Placement [Member] IPO And Private Placement [Member] Public Warrant [Member] Public Warrant [Member] Public warrant. Private Placement Warrant [Member] Private Placement Warrant [Member] Private Placement Warrant [Member] Private Placement [Member] Private Placement [Member] Private Placement And Over Allotment Option [Member] Private Placement And Over Allotment Option [Member] Private Placement And Over Allotment Option [Member] Related Party [Axis] Related Party [Domain] EX-101.PRE 10 frbn-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Cover Page - shares	2 Months Ended
Cover Page - shares	Sep. 30, 2021	Jan. 24, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Registrant Name	FORBION EUROPEAN ACQUISITION CORP.
Entity Central Index Key	0001874495
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	4001 Kennett Pike
Entity Address, Address Line Two	Suite 302
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19807
City Area Code	302
Local Phone Number	273 0765
Entity File Number	001-41148
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	FRBN
Security Exchange Name	NASDAQ
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Trading Symbol	FRBNU
Security Exchange Name	NASDAQ
Redeemable Warrants [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	FRBNW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		12,650,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		3,162,500

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheet

Sep. 30, 2021

USD ($)

Assets:

Deferred offering costs

$ 354,615

Total assets

354,615

Liabilities and Shareholder's Equity

Accrued offering costs and expenses

340,356

Total current liabilities

340,356

Commitments and Contingencies (Note 6)

Shareholder's Equity:

Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding

Additional paid-in capital

24,684

Accumulated deficit

(10,741)

Total shareholder's equity

14,259

Total Liabilities and Shareholder's Equity

354,615

Common Class A [Member]

Shareholder's Equity:

Common stock

Common Class B [Member]

Shareholder's Equity:

Common stock

316

^[1]

Total shareholder's equity

$ 316

[1]

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheet (Parenthetical) - $ / shares

2 Months Ended

Dec. 09, 2021

Sep. 30, 2021

Aug. 13, 2021

Preferred stock par or stated value per share

$ 0.0001

Preferred stock shares authorized

5,000,000

Preferred stock shares issued

Preferred stock shares outstanding

Common Class A [Member]

Common stock par or stated value per share

$ 0.0001

Common stock shares authorized

500,000,000

Common stock shares issued

Common stock, Shares, Outstanding

Common Class B [Member]

Common stock par or stated value per share

^[1]

$ 0.0001

Common stock shares authorized

^[1]

50,000,000

Common stock shares issued

3,162,500

^[1]

2,875,000

Common stock, Shares, Outstanding

3,162,500

^[1]

2,875,000

Common Class B [Member] | Founder shares [Member] | Subsequent Event [Member]

Common stock, Shares, Outstanding

3,162,500

Stockholders' equity note, stock split

1.1

Over-Allotment Option [Member] | Common Class B [Member]

Common shares subject to forfeiture

412,500

[1]

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements Of Operations

2 Months Ended

Sep. 30, 2021

USD ($)

$ / shares

Formation costs

$ 10,741

Net loss

$ (10,741)

Basic and diluted net loss per share | $ / shares

$ 0.00

Common Class B [Member]

Basic and diluted weighted average Class B ordinary shares outstanding | shares

2,750,000

^[1]

[1]

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements Of Operations (Parenthetical) - Common Class B [Member] - shares

2 Months Ended

Dec. 09, 2021

Sep. 30, 2021

Aug. 13, 2021

Common stock shares outstanding

3,162,500

^[1]

2,875,000

Founder Shares [Member] | Subsequent Event [Member]

Stockholders' equity note, stock split

1.1

Common stock shares outstanding

3,162,500

Over-Allotment Option [Member]

Common shares subject to forfeiture

412,500

[1]

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Statement Of Changes In Shareholder's Equity - 2 months ended Sep. 30, 2021 - USD ($)

Total

Common Class B [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Balance at Aug. 08, 2021

Balance, shares at Aug. 08, 2021

^[1]

Class B ordinary shares issued to Sponsor

25,000

$ 316

24,684

Class B ordinary shares issued to Sponsor, Shares

^[1]

3,162,500

Net loss

(10,741)

Balance at Sep. 30, 2021

$ 14,259

$ 316

$ 24,684

$ (10,741)

Balance, shares at Sep. 30, 2021

^[1]

3,162,500

[1]

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 17 R7.htm IDEA: XBRL DOCUMENT

Condensed Statement Of Changes In Shareholder's Equity (Parenthetical) - Common Class B [Member] - shares

2 Months Ended

Dec. 09, 2021

Sep. 30, 2021

Aug. 13, 2021

Common stock shares outstanding

3,162,500

^[1]

2,875,000

Founder Shares [Member] | Subsequent Event [Member]

Stockholders' Equity Note, Stock Split

1.1

Common stock shares outstanding

3,162,500

Over-Allotment Option [Member]

Common shares subject to forfeiture

412,500

[1]

XML 18 R8.htm IDEA: XBRL DOCUMENT

Condensed Statement Of Cash Flows	2 Months Ended
Condensed Statement Of Cash Flows	Sep. 30, 2021 USD ($)
Cash flows from operating activities:
Net loss	$ (10,741)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation cost paid by Sponsor	6,941
Changes in operating assets and liabilities:
Accrued expenses	3,800
Net cash used in operating activities	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	0
Cash, August 9, 2021 (inception)	0
Cash, end of the period	0
Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	18,059
Deferred offering costs included in accrued offerings costs and expenses	$ 336,556

XML 19 R9.htm IDEA: XBRL DOCUMENT

Organization, Business Operation and Liquidity	2 Months Ended
Organization, Business Operation and Liquidity	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Business Operation and Liquidity	Note 1 — Organization, Business Operation and Liquidity Forbion European Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on August 9, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). As of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 9, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering (the “IPO”). The Company has selected December 31 as its fiscal year end. The Company’s Sponsor is Forbion Growth Sponsor FEAC I B.V., a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s the IPO was declared effective on December 9, 2021 (the “Effective Date”). On December 14, 2021, the Company’s consummated the IPO of 11,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8). Simultaneously with the consummation of the IPO and full exercise of the overallotment, the Company consummated the private placement of 5,195,000 warrants (the “Private Placement Warrants”) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8). Transaction costs related to the IPO amounted to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $907,500 in transaction costs for aggregate transaction costs of $6,510,013 consisting of $2,130,000 of underwriting commissions, $3,727,500 of deferred underwriting commissions and $652,513 of other offering costs (see Note 8). In addition, $1,641,236 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500 deposit in advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act , having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association, as discussed below and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to its public shareholders, until the earliest of (a) the completion of the initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the limitations described herein, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, and (c) the redemption of the public shares if the Company has not consummated the Company’s Business Combination within the Combination Period, subject to applicable law. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The funds held in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of its public shareholders. As it is expected that we are and will continuously be considered a Dutch tax resident, any redemption proceeds (including interest income on the trust account) distributed to our shareholders in excess of the paid-up capital for Dutch tax purposes may be subject to 15% Dutch dividend withholding tax. The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement. The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account is initially anticipated to be $10.25 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated memorandum and articles of association provides that the Company will have only 18 months from the closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period. The Sponsor and each member of its management team have entered into an agreement with Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (ii) to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame). The Company has until 18 months from the closing of the IPO to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within the Combination Period. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account, for each additional three-month period , $1,265,000 ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.25 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations. Liquidity and Capital Resources Prior to the completion of the IPO, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. The Company has since completed its IPO at which time capital in excess of the funds deposited in the trust and used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since re-evaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year form the date the financial statements are issued and therefore substantial doubt has been alleviated. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies	2 Months Ended
Significant Accounting Policies	Sep. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus, which contains the initial audited financial statements and notes thereto for the period from August 9, 2021 (inception) to August 13, 2021 as filed with the SEC on December 13, 2021, and the Company’s report on Form 8-K, which contains the Company’s audited balance sheet and notes thereto as of December 14, 2021, as filed with the SEC on December 21, 2021. The interim results for the three months ended September 30, 2021 and for the period from August 9, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021. Offering Costs associated with the IPO Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Upon initial closing of the IPO on December 14, 2021, offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to shareholders’ equity. The Company incurred offering costs amounting to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 11,000,000 Class A ordinary shares subject to possible redemption (12,650,000 Class A ordinary shares subject to possible redemption following the full exercise of the underwriters’ over-allotment option on December 15, 2021) are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 412,500 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters (see Note 5). At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. Income Taxes The Company follows the asset and liability method of accounting for income taxes under Financial Accounting Standards Board (“FASB”) ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

XML 21 R11.htm IDEA: XBRL DOCUMENT

IPO	2 Months Ended
IPO	Sep. 30, 2021
Equity [Abstract]
IPO	Note 3 — IPO On December 14, 2021, the Company consummated its IPO of 11,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8). Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500 deposit in advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

XML 22 R12.htm IDEA: XBRL DOCUMENT

Private Placement	2 Months Ended
Private Placement	Sep. 30, 2021
Private Placement [Abstract]
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 4,700,000 Private Placement Warrants (5,195,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Unit. The sale of the Private Placement W arrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8). The Private Placement Warrants are not be transferable, assignable or salable (and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants are not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination), except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Warrants.” If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the IPO . Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants require a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Related Party Transactions	2 Months Ended
Related Party Transactions	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On August 12, 2021, Forbion European Sponsor LLP paid $25,000, or approximately $0.009 per share, to cover certain offering costs in consideration for 2,875,000 Class B ordinary shares (the “Founder Shares”), par value $0.0001. On November 23, 2021, Forbion European Sponsor LLP transferred 2,875,000 Class B ordinary shares to the Sponsor in exchange for $25,000, or approximately $0.009 per share. On December 9, 2021, the Company issued 287,500 Class B ordinary shares to the Sponsor resulting from a 1.1 for 1 share dividend. Up to 412,500 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. Promissory Note — Related Party On August 12, 2021, Forbion European Sponsor LLP agreed to loan the Company up to $500,000 to be used for a portion of the expenses of the IPO . These loans are non -interest bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO . The loan will be repaid out of the offering proceeds not held in the Trust Account and is now due on demand. Working Capital Loans In order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close. The Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans. Related Party Extension Loans The Company may extend the period of time to consummate a Business Combination by up to two additional three-month periods (for a total of 24 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the trust account, for each additional three-month period, $1,265,000, ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. Any such payments would be made in the form of a non-interest bearing, unsecured promissory note. Such notes would either be paid upon consummation of a Business Combination, or, at the relevant insider’s discretion, converted upon consummation of a Business Combination into additional Private Placement Warrants at a price of $1.50 per Private Warrant. The Sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for the Company to complete a Business Combination. Office Space, Secretarial and Administrative Services Commencing on December 9, 2021, the date that the Company’s securities are first listed on the NASDAQ through the earlier of the consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support and to reimburse the Sponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial Business Combination. Additionally, the Sponsor has agreed to pay an annual salary of $25,000 to each of the independent Board Members for services rendered prior to or in connection with the completion of the Business Combination. Board members are entitled to reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing the Business Combination as well.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies	2 Months Ended
Commitments & Contingencies	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 6 — Commitments & Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and extension loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and extension loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the IPO . The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, as described in the following paragraph, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Except as described herein, the Sponsor and the Company’s directors and executive officers have agreed not to transfer, assign or sell (i) their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company complete a liquidation, merger, share exchange or other similar transaction that results in all of its P ublic S hareholders having the right to exchange their ordinary shares for cash, securities or other property, and (ii) any of their Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of the initial Business Combination. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor with respect to any Founder Shares, Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof. The Company refer to such transfer restrictions throughout this prospectus as the lock-up. In addition, pursuant to the registration and shareholder rights agreement, the Sponsor, upon and following consummation of an initial Business Combination, will be entitled to nominate three individuals for appointment to the Company’s board of directors, as long as the S ponsor holds any securities covered by the registration and shareholder rights agreement. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. Underwriting Agreement The underwriters were granted a 45-day option from the date of the IPO to purchase up to an additional 1,650,000 Units to cover over-allotments, if any. On December 15, 2021, the underwriters fully exercised the over-allotment option (see Note 8). The underwriters were paid underwriting commission of $0.20 per Unit sold in the IPO, excluding Units sold to the anchor investor , or $1,800,000, upon the closing of the IPO. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $330,000 for an aggregate of $2,130,000 in underwriting commissions related to the IPO and over-allotment (see Note 8). In addition, $3,150,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO, excluding those Units sold to the anchor investor . Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $577,500 for an aggregate of $3,727,500 in deferred underwriting commissions related to the IPO and over-allotment (see Note 8). The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreements The Company has entered into two forward purchase agreements with an affiliate of the Sponsor (the “FPA Purchaser”), pursuant to which the FPA Purchaser has agreed to purchase (1) an aggregate of 1,000,000 Class A ordinary shares for $10.00 per share (the “firm forward purchase shares”), or an aggregate amount of $10,000,000 and (2) in addition, an aggregate of up to 1,000,000 Class A ordinary shares for $10.00 per share (the “additional forward purchase shares”), or an aggregate maximum amount of up to $10,000,000, in each case in a private placement that may close simultaneously with the closing of the Company’s initial Business Combination.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Shareholder's Equity

2 Months Ended

Sep. 30, 2021

Equity [Abstract]

Shareholder's Equity

Note 7 — Shareholder’s Equity

Preference shares

— The

Class

A ordinary shares

— The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021, there were no Class A ordinary shares outstanding.

Class

B ordinary shares

of the Company’s issued and outstanding ordinary shares after the

IPO

. As of September 30, 2021, there were 3,162,500 Class B ordinary shares outstanding.

. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least

two-thirds

as-converted

basis, 20%

than

one-to-one.

Public Warrants

Redemption of public warrants

. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption, which the Company refer to as the

“30-day

redemption period”; and

•

30-trading

day period ending on the third trading day prior to the date on which the Company send the notice of redemption to the warrant holders.

30-day

10-day

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 26 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

2 Months Ended

Sep. 30, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 8 — Subsequent Events

On December

Simultaneously with the consummation of th

In connection with the IPO, the Company entered into the following agreements:

•

An Underwriting Agreement, dated December 9, 2021, between the Company, UBS Securities LLC and Kempen & Co. USA, Inc. (the “

Underwriting Agreement

”).

•

The Amended and Restated Memorandum and Articles of Association of the Company, dated December 9, 2021.

•

A Warrant Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

•

A Letter Agreement, dated December 9, 2021, between the Company and its officers, directors and the Sponsor.

•

An Investment Management Trust Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.

•

A Registration and Shareholder Rights Agreement, dated December 9, 2021, among the Company and the Sponsor.

•

An Administrative Services Agreement, dated December 9, 2021, between the Company and the Sponsor.

•

A Private Placement Warrants Purchase Agreement, dated December 9, 2021, between the Company and the Sponsor.

•

Indemnity Agreements, each dated December 9, 2021, between the Company and each of its executive officers and directors.

•

A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V.

•

A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	2 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus, which contains the initial audited financial statements and notes thereto for the period from August 9, 2021 (inception) to August 13, 2021 as filed with the SEC on December 13, 2021, and the Company’s report on Form 8-K, which contains the Company’s audited balance sheet and notes thereto as of December 14, 2021, as filed with the SEC on December 21, 2021. The interim results for the three months ended September 30, 2021 and for the period from August 9, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.
Offering Costs associated with the IPO	Offering Costs associated with the IPO Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Upon initial closing of the IPO on December 14, 2021, offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to shareholders’ equity. The Company incurred offering costs amounting to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 11,000,000 Class A ordinary shares subject to possible redemption (12,650,000 Class A ordinary shares subject to possible redemption following the full exercise of the underwriters’ over-allotment option on December 15, 2021) are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.
Net Loss Per Share	Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 412,500 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters (see Note 5). At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under Financial Accounting Standards Board (“FASB”) ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Organization, Business Operation and Liquidity - Additional Information (Details) - USD ($)			2 Months Ended
	Dec. 15, 2021	Dec. 14, 2021	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Entity Incorporation Date Of Incorporation			Aug. 09, 2021
Post-transaction ownership percentage of the target entity			50.00%
Term of restricted investments			185 days
Percentage of public shares to be redeemed in case does not complete initial business combination within combination period			100.00%
Percentage of dutch dividend withholding tax			15.00%
Redemption Value Per Share			$ 10.25
Minimum netorth needed to consummate business combination			$ 5,000,001
Threshold period from the closing of public offering to consummate business combination as per amended and restated and restated articles of association			18 months
Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination			24 months
Expenses payable on liquidation			$ 100,000
Period To complete business combination from closing of the Initial Public Offering			18 days
Payments to acquire restricted investment for each additional three month period			$ 1,265,000
Payments to acquire restricted investment for each additional three month period, Per share			$ 0.10
Minimum Per Share Amount To Be Maintained In The Trust Account			$ 10.25
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Fair market value as percentage of net assets held in trust account included in initial business combination			80.00%
Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Offering costs		$ 5,602,513
Underwriting commissions		1,800,000
Deferred underwriting commissions		3,150,000
Other Offering Costs		652,513
Investment of cash in Trust Account	$ 129,662,500	$ 113,492,500
Cash deposited in Trust Account per Unit		$ 10.25
Additional Deposit In advance From Related Party Deposited In Restricted Investments		$ 742,500
Term of restricted investments	185 days
Subsequent Event [Member] \| Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights warrants issued during the period		5,195,000
Class of warrants or rights warrants issued issue price per warrant		$ 1.50
Proceeds from private placement of warrants		$ 7,792,500
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock par or stated value per share			$ 0.0001
IPO [Member] \| Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Investment of cash in Trust Account		$ 11,000,000
IPO [Member] \| Subsequent Event [Member] \| Public Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares issued upon exercise of warrant		1
Exercise price of warrant		$ 11.50
IPO [Member] \| Common Class A [Member] \| Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues		11,000,000
Shares issued price per share		$ 10.00
Number of shares included in Unit		1
Proceeds from issuance initial public offering		$ 126,500,000
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cash			$ 1,641,236
Over-Allotment Option [Member] \| Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Underwriting commissions		2,130,000
Deferred underwriting commissions		3,727,500
Other Offering Costs		652,513
Additional transaction costs		907,500
Aggregate Transaction Costs		6,510,013
Investment of cash in Trust Account		$ 10.25
Cash deposited in Trust Account per Unit		$ 129,662,500
Over-Allotment Option [Member] \| Common Class A [Member] \| Subsequent Event [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues		12,650,000

XML 29 R19.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Additional Information (Details) - USD ($)		2 Months Ended
	Dec. 14, 2021	Sep. 30, 2021
Accounting Policies [Line Items]
Cash equivalents at carrying value		$ 0
Dilutive securities		0
Unrecognized tax benefits		$ 0
Accrued amounts for interest and penalties for unrecognized tax benefits		0
Cash insrued with federal deposit insurance corporation		$ 250,000
Common Class A [Member]
Accounting Policies [Line Items]
Number of Ordinary shares subject to possible redemptions		11,000,000
Common Class A [Member] \| Over-Allotment Option [Member]
Accounting Policies [Line Items]
Number of Ordinary shares subject to possible redemptions		12,650,000
Common Class B [Member] \| Over-Allotment Option [Member]
Accounting Policies [Line Items]
Weighted average number of shares common stock subject to repurchase or cancellation		412,500
Subsequent Event [Member]
Accounting Policies [Line Items]
Offering costs	$ 5,602,513
Underwriting commissions	1,800,000
Deferred underwriting commissions	3,150,000
Other Offering Costs	652,513
Subsequent Event [Member] \| Over-Allotment Option [Member]
Accounting Policies [Line Items]
Underwriting commissions	2,130,000
Deferred underwriting commissions	3,727,500
Other Offering Costs	$ 652,513

XML 30 R20.htm IDEA: XBRL DOCUMENT

IPO - Additional Information (Details) - USD ($)			2 Months Ended
IPO - Additional Information (Details) - USD ($)	Dec. 15, 2021	Dec. 14, 2021	Sep. 30, 2021
Disclosure Of Initial Public Offering [Line Items]
Common stock, Conversion basis			one-to-one
Term of restricted investments			185 days
Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Payments to acquire restricted investment	$ 129,662,500	$ 113,492,500
Payments to acquire restricted investment, Per unit	$ 10.25
Term of restricted investments	185 days
IPO [Member] \| Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Payments to acquire restricted investment		11,000,000
IPO And Private Placement [Member] \| Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Payments to acquire restricted investment		$ 113,492,500
Payments to acquire restricted investment, Per unit		$ 10.25
Advance from the sponsor deposited in trust account		$ 742,500
Common Class A [Member] \| Public Warrant [Member]
Disclosure Of Initial Public Offering [Line Items]
Class of warrant or right, Exercise price of warrants or rights			$ 11.50
Common Class A [Member] \| Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Proceeds from issuance initial public offering and over allotment option, Gross	$ 126,500,000
Common Class A [Member] \| IPO [Member] \| Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period, Shares		11,000,000
Shares issued, Price per share		$ 10.00
Common stock, Conversion basis		consists of one Class A ordinary share and one-third of one redeemable warrant.
Common Class A [Member] \| IPO [Member] \| Subsequent Event [Member] \| Public Warrant [Member]
Disclosure Of Initial Public Offering [Line Items]
Class of warrant or right, Number of securities called by each warrant or right		1
Class of warrant or right, Exercise price of warrants or rights		$ 11.50
Common Class A [Member] \| IPO And Over Allotment Option [Member] \| Subsequent Event [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period, Shares	12,650,000

XML 31 R21.htm IDEA: XBRL DOCUMENT

Private Placement - Additional Information (Details) - Private Placement Warrant [Member]		2 Months Ended
	Dec. 15, 2021 USD ($) shares	Sep. 30, 2021 d	Dec. 14, 2021 $ / shares shares
Private Placement [Line Items]
Class of warrants or rights issued during period, Warrants	5,195,000
Minimum [Member]
Private Placement [Line Items]
Percentage of outstanding private placement warrant held by holders who vote in amending terms of warrant		50.00%
Private Placement [Member] \| Sponsor [Member] \| Subsequent Event [Member]
Private Placement [Line Items]
Class of warrants or rights issued during period, Warrants	4,700,000
Warrants issued, Price per warrant \| $ / shares			$ 1.50
Common Class A [Member]
Private Placement [Line Items]
Lock up period \| d		30
Common Class A [Member] \| Sponsor [Member] \| Subsequent Event [Member]
Private Placement [Line Items]
Class of warrant or right, Number of securities called by each warrant or right			1
Class of warrant or right, Exercise price of warrants or rights \| $ / shares			$ 11.50
Private Placement And Over Allotment Option [Member] \| Sponsor [Member] \| Subsequent Event [Member]
Private Placement [Line Items]
Proceeds from issuance of warrants \| $	$ 7,792,500

XML 32 R22.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Details) - USD ($)

2 Months Ended

Dec. 09, 2021

Nov. 23, 2021

Sep. 30, 2021

Aug. 12, 2021

Sep. 30, 2021

Aug. 13, 2021

Stock issued during period, Value, Issued for services

$ 25,000

Business combination, Consummation period, Extension terms

two additional three-month periods

Extended period within which business combination shall be consummated

24 months

Payments to acquire restricted investment for each additional three month period

$ 1,265,000

Working Capital Loans [Member]

Debt Instrument, Convertible, Carrying Amount of Equity Component

$ 1,500,000

Debt Instrument, Convertible, Conversion Price

$ 1.50

Bank Overdrafts

$ 0

Extension Loans [Member]

Debt Instrument, Convertible, Conversion Price

$ 1.50

Extension Loans [Member] | Inorder To Extend Consummation Period [Member]

Payments to acquire restricted investment for each additional three month period

$ 1,265,000

Payments to acquire restricted investment for each additional three month period, Per share

0.10%

Subsequent Event [Member] | Founder shares [Member] | Over-Allotment Option [Member]

Common stock, other shares, outstanding

412,500

Forbion European Sponsor LLP [Member]

Stock issued during period, Value, Issued for services

$ 25,000

Shares Issued, Price Per Share

$ 0.009

Common Stock, Par or Stated Value Per Share

$ 0.0001

Debt Instrument, Face Amount

$ 500,000

Sponsor [Member] | Subsequent Event [Member] | Office Space Secretarial And Administrative Services [Member]

$ 10,000

Sponsor [Member] | Subsequent Event [Member] | Salary [Member]

$ 25,000

Common Class B [Member]

Stock issued during period, Value, Issued for services

$ 316

Stock issued during period, Shares, Issued for services

^[1]

3,162,500

Common Stock, Par or Stated Value Per Share

^[2]

$ 0.0001

Common Class B [Member] | Over-Allotment Option [Member]

Common stock, other shares, outstanding

375,000

Common Class B [Member] | Subsequent Event [Member] | Founder shares [Member] | Over-Allotment Option [Member]

Common stock, other shares, outstanding

412,500

Common Class B [Member] | Forbion European Sponsor LLP [Member]

Stock issued during period, Shares, Issued for services

2,875,000

Common Class B [Member] | Sponsor [Member] | Subsequent Event [Member]

Stock issued during period, Shares, Issued for services

287,500

Common Class B [Member] | Sponsor [Member] | Subsequent Event [Member] | Transfer Between Forbion European Sponsor LLP And Sponsor [Member]

Stock issued during period, Value, Issued for services

$ 25,000

Shares Issued, Price Per Share

$ 0.009

Stock issued during period, Shares, Issued for services

2,875,000

[1]

[2]

XML 33 R23.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies - Additional Information (Details)	Dec. 15, 2021 USD ($)	Dec. 14, 2021 USD ($) shares	Sep. 30, 2021 USD ($) d Day $ / shares shares
Underwriting commission, Per unit		0.20%
Subsequent Event [Member]
Payments for underwriting expense		$ 1,800,000
Restriction On Transfer Of Founder Shares [Member] \| Share Price Equals Or Exceeds Twelve USD [Member]
Number of trading days determining share price			20 days
Number of consecutive trading days determining share price			30 days
Threshold number of trading days determining share price			150 days
Founder Shares [Member] \| Restriction On Transfer Of Founder Shares [Member]
Lock up period \| d			1
Common Class A [Member] \| Restriction On Transfer Of Founder Shares [Member] \| Share Price Equals Or Exceeds Twelve USD [Member]
Share price \| $ / shares			$ 12.00
Registration And Shareholder Rights Agreement [Member]
Number of demands that can be made \| Day			3
Number of individuals for appointment to the board of directors nominated by sponsor \| Day			3
Registration And Shareholder Rights Agreement [Member] \| Common Class A [Member] \| Private Placement Warrant [Member]
Lock up period \| d			30
Underwriting Agreement [Member] \| Over-Allotment Option [Member] \| Subsequent Event [Member]
Payments for underwriting expense	$ 330,000
Deferred compensation liability, Noncurrent	577,500
Underwriting Agreement [Member] \| IPO [Member] \| Subsequent Event [Member]
Deferred compensation liability, Noncurrent		$ 3,150,000
Underwriting Agreement [Member] \| IPO And Over Allotment Option [Member] \| Subsequent Event [Member]
Payments for underwriting expense	2,130,000
Deferred compensation liability, Noncurrent	$ 3,727,500
Underwriting Agreement [Member] \| Common Class A [Member] \| Over-Allotment Option [Member] \| Subsequent Event [Member]
Option vesting period	45 days
Common stock, shares subscribed but unissued \| shares		1,650,000
Forward Purchase Agreements [Member] \| FPA Purchaser [Member]
Number of agreements \| Day			2
Forward Purchase Agreements [Member] \| Common Class A [Member] \| Firm Forward Purchase Shares [Member] \| Private Placement [Member] \| FPA Purchaser [Member]
Share price \| $ / shares			$ 10.00
Common stock, shares subscribed but unissued \| shares			1,000,000
Common stock, value, subscriptions			$ 10,000,000
Forward Purchase Agreements [Member] \| Common Class A [Member] \| Additional Forward Purchase Shares [Member] \| Private Placement [Member] \| FPA Purchaser [Member]
Share price \| $ / shares			$ 10.00
Common stock, shares subscribed but unissued \| shares			1,000,000
Common stock, value, subscriptions			$ 10,000,000

XML 34 R24.htm IDEA: XBRL DOCUMENT

Shareholder's Equity - Additional Information (Details)

2 Months Ended

Dec. 14, 2021

$ / shares

Dec. 09, 2021

Sep. 30, 2021

Classes

$ / shares

Sep. 30, 2021

Classes

$ / shares

Aug. 13, 2021

USD ($)

Preferred stock par or stated value per share | $ / shares

$ 0.0001

Preferred stock shares authorized

5,000,000

Preferred stock shares issued

Preferred stock shares outstanding

Board of directors, Service term

3 years

Number of class of directors being appointed in each year | Classes

Common stock, threshold percentage on conversion of shares

20.00%

Common stock, Conversion basis

one-to-one

Number of trading days determining volume weighted average trading price of common stock

20 days

Number of days after consummation of business combination within which securities registration shall be effective

60 days

Number Of Days Of Average Closing Price determining Fair Market Value

10 days

Share Price Equals Or Exceeds Eighteen USD [Member]

Number of trading days determining share price

20 days

Number of consecutive trading days determining share price

30 days

Public Warrant [Member]

Period after which the warrants are exercisable

30 days

Warrants and rights outstanding, Term

5 years

Class of warrant or right, Redemption price per warrant

0.01

Minimum notice of redemption period

30 days

Minimum [Member]

Percentage holding of common stock eligible for voting of directors

50.00%

Over-Allotment Option [Member] | Subsequent Event [Member] | Founder Shares [Member]

Common stock, other shares, outstanding

412,500

Common Class A [Member]

Common stock par or stated value per share | $ / shares

$ 0.0001

Common stock shares authorized

500,000,000

Common stock, Shares, Issued

Common stock, Shares, Outstanding

Common Class A [Member] | Share Price Equals Or Exceeds Eighteen USD [Member]

Share price | $ / shares

$ 18.00

Common Class A [Member] | Public Warrant [Member]

Class of warrant or right, Exercise price of warrants or rights | $ / shares

11.50

$ 11.50

Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total

60.00%

Common Class A [Member] | Public Warrant [Member] | Volume Weighted Average Trading Price Below Nine Point Twenty USD [Member]

Number of trading days determining volume weighted average trading price of common stock

20 days

Volume weighted average trading price of common stock

9.20

Class of Warrants Exercise Price Adjustment Percentage

115.00%

Common Class A [Member] | Public Warrant [Member] | Share Price Less Than Nine Point Twenty USD [Member]

Share price | $ / shares

$ 9.20

Common Class A [Member] | Public Warrant [Member] | Share Price At Eighteen USD [Member]

Class of Warrants Exercise Price Adjustment Percentage

180.00%

Redemption trigger price per share

18.00

Common Class A [Member] | Public Warrant [Member] | Share Price Below Eighteen USD [Member]

Redemption trigger price per share

18.00

Common Class A [Member] | IPO [Member] | Subsequent Event [Member]

Common stock, Conversion basis

consists of one Class A ordinary share and one-third of one redeemable warrant.

Common Class A [Member] | IPO [Member] | Subsequent Event [Member] | Public Warrant [Member]

Class of warrant or right, Number of securities called by each warrant or right

Class of warrant or right, Exercise price of warrants or rights | $ / shares

$ 11.50

Common Class B [Member]

Common stock par or stated value per share | $ / shares

^[1]

$ 0.0001

Common stock shares authorized

^[1]

50,000,000

Common stock, Shares, Issued

3,162,500

^[1]

3,162,500

^[1]

2,875,000

Common stock, Shares, Outstanding

3,162,500

^[1]

3,162,500

^[1]

2,875,000

Common stock, Voting rights

one

Percentage of ownership held by initial shareholders after the Public Offer

20.00%

Common Class B [Member] | Subsequent Event [Member] | Stock Dividend For Each Outstanding Share [Member]

Stock dividend, Per share

1.1

Common Class B [Member] | Subsequent Event [Member] | Founder Shares [Member]

Common stock, Shares, Outstanding

3,162,500

Common Class B [Member] | Over-Allotment Option [Member]

Common stock, other shares, outstanding

375,000

Common stock, Other value, Outstanding | $

$ 0

Common Class B [Member] | Over-Allotment Option [Member] | Subsequent Event [Member] | Founder Shares [Member]

Common stock, other shares, outstanding

412,500

[1]

XML 35 R25.htm IDEA: XBRL DOCUMENT

Subsequent Events - Additional Information (Details) - USD ($)

Dec. 15, 2021

Dec. 14, 2021

Dec. 09, 2021

Sep. 30, 2021

Aug. 13, 2021

Common Class B [Member]

Common stock, Shares, Outstanding

3,162,500

^[1]

2,875,000

Common Class B [Member] | Subsequent Event [Member] | Stock Dividend For Each Outstanding Share [Member]

Stock dividend, Per share

1.1

Common Class B [Member] | Subsequent Event [Member] | Founder Shares [Member]

Common stock, Shares, Outstanding

3,162,500

Common Class A [Member]

Common stock, Shares, Outstanding

Common Class A [Member] | Subsequent Event [Member]

Proceeds from issuance initial public offering and over allotment option, Gross

$ 126,500,000

Common Class A [Member] | IPO [Member] | Subsequent Event [Member]

Stock issued during period, Shares

11,000,000

Shares issued, Price per share

$ 10.00

Common Class A [Member] | IPO And Over Allotment Option [Member] | Subsequent Event [Member]

Stock issued during period, Shares

12,650,000

Private Placement Warrant [Member] | Sponsor [Member] | Private Placement [Member]

Class of warrants or rights issued during period, Warrants

4,700,000

Private Placement Warrant [Member] | Sponsor [Member] | Private Placement [Member] | Subsequent Event [Member]

Warrants issued, Price per warrant

$ 1.50

Private Placement Warrant [Member] | Sponsor [Member] | Private Placement And Over Allotment Option [Member] | Subsequent Event [Member]

Class of warrants or rights issued during period, Warrants

5,195,000

Proceeds from issuance of warrants

$ 7,792,500

[1]

XML 36 d250880d10q_htm.xml IDEA: XBRL DOCUMENT 0001874495 2021-08-09 2021-09-30 0001874495 2021-09-30 0001874495 2021-12-09 2021-12-09 0001874495 2021-09-30 2021-09-30 0001874495 2021-12-14 0001874495 2021-08-08 0001874495 us-gaap:CommonClassAMember 2022-01-24 0001874495 us-gaap:CommonClassBMember 2022-01-24 0001874495 us-gaap:CapitalUnitsMember 2021-08-09 2021-09-30 0001874495 frbn:RedeemableWarrantsMember 2021-08-09 2021-09-30 0001874495 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-08-09 2021-09-30 0001874495 us-gaap:CommonClassBMember 2021-08-09 2021-09-30 0001874495 us-gaap:AdditionalPaidInCapitalMember 2021-08-09 2021-09-30 0001874495 us-gaap:RetainedEarningsMember 2021-08-09 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember 2021-08-09 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember frbn:VolumeWeightedAverageTradingPriceBelowNinePointTwentyUsdMember 2021-08-09 2021-09-30 0001874495 srt:MinimumMember 2021-08-09 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember frbn:SharePriceAtEighteenUsdMember 2021-08-09 2021-09-30 0001874495 frbn:PublicWarrantMember 2021-08-09 2021-09-30 0001874495 frbn:SharePriceEqualsOrExceedsEighteenUsdMember 2021-08-09 2021-09-30 0001874495 frbn:PrivatePlacementWarrantMember us-gaap:CommonClassAMember 2021-08-09 2021-09-30 0001874495 us-gaap:CommonClassAMember 2021-09-30 0001874495 us-gaap:CommonClassBMember 2021-09-30 0001874495 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-09-30 0001874495 srt:MinimumMember 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember frbn:SharePriceLessThanNinePointTwentyUsdMember 2021-09-30 0001874495 us-gaap:CommonClassAMember frbn:SharePriceEqualsOrExceedsEighteenUsdMember 2021-09-30 0001874495 us-gaap:OverAllotmentOptionMember 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember frbn:SharePriceBelowEighteenUsdMember 2021-09-30 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember frbn:SharePriceAtEighteenUsdMember 2021-09-30 0001874495 frbn:PublicWarrantMember 2021-09-30 0001874495 frbn:WorkingCapitalLoansMember 2021-09-30 0001874495 frbn:ExtensionLoansMember 2021-09-30 0001874495 frbn:ExtensionLoansMember frbn:InorderToExtendConsummationPeriodMember 2021-09-30 0001874495 frbn:RegistrationAndShareholderRightsAgreementMember 2021-09-30 0001874495 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember frbn:ForwardPurchaseAgreementsMember frbn:FirmForwardPurchaseSharesMember frbn:FpaPurchaserMember 2021-09-30 0001874495 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember frbn:ForwardPurchaseAgreementsMember frbn:AdditionalForwardPurchaseSharesMember frbn:FpaPurchaserMember 2021-09-30 0001874495 us-gaap:CommonClassAMember frbn:RestrictionOnTransferOfFounderSharesMember frbn:SharePriceEqualsOrExceedsTwelveUsdMember 2021-09-30 0001874495 frbn:ForwardPurchaseAgreementsMember frbn:FpaPurchaserMember 2021-09-30 0001874495 srt:MinimumMember frbn:PrivatePlacementWarrantMember 2021-09-30 0001874495 us-gaap:CommonClassBMember frbn:FounderSharesMember us-gaap:SubsequentEventMember 2021-12-09 0001874495 us-gaap:CommonClassBMember frbn:FounderSharesMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-12-09 0001874495 frbn:FounderSharesMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-12-09 0001874495 us-gaap:CommonClassBMember frbn:FounderSharesMember us-gaap:SubsequentEventMember 2021-12-09 2021-12-09 0001874495 frbn:StockDividendForEachOutstandingShareMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2021-12-09 2021-12-09 0001874495 frbn:SponsorMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2021-12-09 2021-12-09 0001874495 frbn:OfficeSpaceSecretarialAndAdministrativeServicesMember frbn:SponsorMember us-gaap:SubsequentEventMember 2021-12-09 2021-12-09 0001874495 frbn:SalaryMember frbn:SponsorMember us-gaap:SubsequentEventMember 2021-12-09 2021-12-09 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-12-14 2021-12-14 0001874495 frbn:SponsorMember frbn:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2021-12-14 2021-12-14 0001874495 us-gaap:SubsequentEventMember 2021-12-14 2021-12-14 0001874495 us-gaap:SubsequentEventMember frbn:IPOAndPrivatePlacementMember 2021-12-14 2021-12-14 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-12-14 2021-12-14 0001874495 frbn:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember 2021-12-14 2021-12-14 0001874495 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-12-14 2021-12-14 0001874495 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-12-14 2021-12-14 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember frbn:IPOAndOverAllotmentOptionMember 2021-12-15 2021-12-15 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2021-12-15 2021-12-15 0001874495 frbn:SponsorMember frbn:PrivatePlacementWarrantMember us-gaap:SubsequentEventMember frbn:PrivatePlacementAndOverAllotmentOptionMember 2021-12-15 2021-12-15 0001874495 us-gaap:SubsequentEventMember 2021-12-15 2021-12-15 0001874495 frbn:PrivatePlacementWarrantMember 2021-12-15 2021-12-15 0001874495 frbn:PrivatePlacementWarrantMember frbn:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-12-15 2021-12-15 0001874495 frbn:PrivatePlacementWarrantMember frbn:SponsorMember us-gaap:SubsequentEventMember frbn:PrivatePlacementAndOverAllotmentOptionMember 2021-12-15 2021-12-15 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-15 2021-12-15 0001874495 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-15 2021-12-15 0001874495 us-gaap:SubsequentEventMember frbn:IPOAndOverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-15 2021-12-15 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-12-14 0001874495 frbn:SponsorMember frbn:PrivatePlacementWarrantMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-12-14 0001874495 us-gaap:SubsequentEventMember 2021-12-14 0001874495 frbn:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-12-14 0001874495 us-gaap:SubsequentEventMember frbn:IPOAndPrivatePlacementMember 2021-12-14 0001874495 frbn:PrivatePlacementWarrantMember frbn:SponsorMember us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2021-12-14 0001874495 frbn:PrivatePlacementWarrantMember frbn:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2021-12-14 0001874495 frbn:PublicWarrantsMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-12-14 0001874495 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-12-14 0001874495 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-14 0001874495 us-gaap:SubsequentEventMember us-gaap:IPOMember frbn:UnderwritingAgreementMember 2021-12-14 0001874495 us-gaap:CommonClassBMember 2021-08-13 0001874495 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-08-13 0001874495 us-gaap:SubsequentEventMember 2021-12-15 0001874495 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-15 0001874495 us-gaap:SubsequentEventMember frbn:IPOAndOverAllotmentOptionMember frbn:UnderwritingAgreementMember 2021-12-15 0001874495 frbn:ForbionEuropeanSponsorLLPMember 2021-08-12 0001874495 frbn:ForbionEuropeanSponsorLLPMember 2021-08-12 2021-08-12 0001874495 frbn:ForbionEuropeanSponsorLLPMember us-gaap:CommonClassBMember 2021-08-12 2021-08-12 0001874495 frbn:TransferBetweenForbionEuropeanSponsorLLPAndSponsorMember frbn:SponsorMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2021-11-23 0001874495 frbn:TransferBetweenForbionEuropeanSponsorLLPAndSponsorMember frbn:SponsorMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2021-11-23 2021-11-23 0001874495 frbn:ExtensionLoansMember frbn:InorderToExtendConsummationPeriodMember 2021-09-30 2021-09-30 0001874495 frbn:PrivatePlacementWarrantMember us-gaap:CommonClassAMember frbn:RegistrationAndShareholderRightsAgreementMember 2021-09-30 2021-09-30 0001874495 frbn:FounderSharesMember frbn:RestrictionOnTransferOfFounderSharesMember 2021-09-30 2021-09-30 0001874495 frbn:RestrictionOnTransferOfFounderSharesMember frbn:SharePriceEqualsOrExceedsTwelveUsdMember 2021-09-30 2021-09-30 0001874495 us-gaap:CommonClassBMember 2021-08-08 0001874495 us-gaap:AdditionalPaidInCapitalMember 2021-08-08 0001874495 us-gaap:RetainedEarningsMember 2021-08-08 0001874495 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001874495 us-gaap:RetainedEarningsMember 2021-09-30 shares iso4217:USD pure utr:Year utr:Day utr:Month iso4217:USD shares frbn:Classes utr:D false Q3 --12-31 0001874495 P20D 10-Q true 2021-09-30 2021 false FORBION EUROPEAN ACQUISITION CORP. E9 001-41148 4001 Kennett Pike Suite 302 Wilmington DE 19807 302 273 0765 Class A ordinary shares, par value $0.0001 per share FRBN NASDAQ Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FRBNW NASDAQ Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant FRBNU NASDAQ No Yes Non-accelerated Filer true true false true 12650000 3162500

354615

340356

0.0001

5000000

0.0001

500000000

0.0001

50000000

3162500

316

24684

-10741

14259

354615

412500

1.1

3162500

10741

-10741

2750000

0.00

412500

1.1

3162500

316

24684

25000

-10741

3162500

316

24684

-10741

14259

412500

1.1

3162500

-10741

6941

3800

18059 336556

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Organization, Business Operation and Liquidity </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forbion European Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on August 9, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar </div><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">business combination with one or more businesses or entities (the “Business Combination”). </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">As of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 9, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering (the “IPO”). The Company has selected December 31 as its fiscal year end. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor is Forbion Growth Sponsor FEAC I B.V., a Cayman Islands limited liability company (the “Sponsor”). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The registration statement for the Company’s the IPO was declared effective on December 9, 2021 (the “Effective Date”). On December 14, 2021, the Company’s consummated the IPO of 11,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">Simultaneously with the consummation of the IPO and full exercise of the overallotment, the Company consummated the private placement of 5,195,000 warrants (the “Private Placement Warrants”) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement <div style="display:inline;">Warrants </div>in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs related to the IPO amounted to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $907,500 in transaction costs for aggregate transaction costs of $6,510,013 consisting of $2,130,000 of underwriting commissions, $3,727,500 of deferred underwriting commissions and $652,513 of other offering costs (see Note 8). In addition, $1,641,236 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50%</div><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;"> </div>or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;">This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500<div style="display:inline;"> deposit in advance </div>from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act<div style="display:inline;">,</div> having a maturity of 185 days<div style="display:inline;"><div style="display:inline;"> </div>or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association, as discussed below and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to its public shareholders, until the earliest of (a) the completion of the initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the limitations described herein, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to </div>redeem 100% of<div style="display:inline;"><div style="display:inline;"> </div>the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, and (c) the redemption of the public shares if the Company has not consummated the Company’s Business Combination within the Combination Period, subject to applicable law. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The funds held in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of its public shareholders. As it is expected that we are and will continuously be considered a Dutch tax resident, any redemption proceeds (including interest income on the trust account) distributed to our shareholders in excess of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-up</div> capital for Dutch tax purposes may be subject </div>to 15% Dutch dividend withholding tax. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding Public Shares, subject to the limitations described herein. The amount in the Trust Account is initially </div>anticipated to be $10.25 per public share. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;">The Company’s amended and restated memorandum and articles of association provides that the Company will have only 18 months from the closing of the<div style="display:inline;"> IPO </div>(or up to 24 months<div style="display:inline;"><div style="display:inline;"> </div>from the closing of this offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to </div>$100,000<div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;"> </div>of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and each member of its management team have entered into an agreement with Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (ii) to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame). </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has until 18 months</div><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="display:inline;"> </div>from the closing of the IPO to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within the Combination Period. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account, for each additional three-month period</div></div><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, $1,265,000 ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.25 </div><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Capital Resources </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">Prior to the completion of the IPO, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. The Company has since completed its IPO at which time capital in excess of the funds deposited in the trust and used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-evaluated</div> the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year form the date the financial statements are issued and therefore substantial doubt has been alleviated. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and Uncertainties </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Management is currently evaluating the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div>

2021-08-09

11000000

10.00

11.50

12650000

126500000

5195000 1.50

7792500

5602513 1800000 3150000 652513 907500 6510013 2130000 3727500 652513

1641236

0.80 0.50

113492500

10.25

11000000

742500 129662500

10.25

P185D 1 0.15

0.0001

10.25

5000001

P18M P24M

100000

P18D 1265000 0.10 10.25

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Significant Accounting Policies </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus, which contains the initial audited financial statements and notes thereto for the period from August 9, 2021 (inception) to August 13, 2021 as filed with the SEC on December 13, 2021, and the Company’s report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K,</div> which contains the Company’s audited balance sheet and notes thereto as of December 14, 2021, as filed with the SEC on December 21, 2021. The interim results for the three months ended September 30, 2021 and for the period from August 9, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company Status </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021. </div></div> <div style="text-indent: 0px;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs associated with the IPO </div></div></div></div> <div style="text-indent: 0px;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1.</div></div></div> Offering costs are allocated ratably with the redeemable and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares they are allocated to. Upon <div style="display:inline;">initial </div>closing of the IPO on December 14, 2021, offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to shareholders’ equity. The Company incurred offering costs amounting to $5,602,513 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $652,513 of other offering costs. </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 11,000,000 Class A ordinary shares subject to possible redemption (12,650,000 Class A ordinary shares subject to possible redemption following the full exercise of the underwriters’ over-allotment option on December 15, 2021) are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss Per Share </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 412,500 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters (see Note 5). At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under Financial Accounting Standards Board (“FASB”) ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Pronouncements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt—Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all convertible instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> would have on its financial position, results of operations or cash flows. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. </div></div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus, which contains the initial audited financial statements and notes thereto for the period from August 9, 2021 (inception) to August 13, 2021 as filed with the SEC on December 13, 2021, and the Company’s report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K,</div> which contains the Company’s audited balance sheet and notes thereto as of December 14, 2021, as filed with the SEC on December 21, 2021. The interim results for the three months ended September 30, 2021 and for the period from August 9, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. </div>

11000000

12650000

412500

250000

<div style="text-indent: 0px;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3 — IPO</div></div></div></div> <div style="text-indent: 0px; background: none;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">On December 14, 2021, the Company consummated its IPO of 11,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000 (see Note 8). </div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;">Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in addition to a $742,500 <div style="letter-spacing: 0px; top: 0px;;display:inline;">deposit in advance from </div>the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021 (see Note 8). Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> under the Investment Company Act which invest only in direct U.S. government treasury obligations. </div>

11000000

10.00

consists of one Class A ordinary share and one-third of one redeemable warrant.

11.50

12650000

126500000

113492500

10.25

11000000

742500

129662500

10.25 P185D <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4 — Private Placement </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 4,700,000 Private Placement Warrants (5,195,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Unit. The sale of the Private Placement <div style="letter-spacing: 0px; top: 0px;;display:inline;">W</div>arrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500 (see Note 8). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are not be transferable, assignable or salable (and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants are not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination), except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Warrants.” </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">IPO</div>. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants require a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants. </div></div> 4700000 5195000

11.50

1.50

7792500

30 0.50

25000

0.009

2875000

0.0001

2875000

25000

0.009

287500

412500

500000

1500000

1.50

two additional three-month periods P24M 1265000 0.0010

1.50

10000

25000

3 30 1

12.00

P20D P30D P150D 30 3 P45D

1650000

0.0020

1800000

330000

2130000

3150000

577500

3727500

1000000

10.00

10000000

1000000

10.00

10000000

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7 — Shareholder’s Equity </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference shares</div></div></div></div> — The </div> Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September, 2021, there were no preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A ordinary shares </div></div></div></div>— The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021, there were no Class A ordinary shares outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B ordinary shares </div></div></div></div>— The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of August 13, 2021, there were 2,875,000 Class B ordinary shares issued and outstanding. Of the 2,875,000 Class B ordinary shares, an aggregate of up to 375,000 shares are subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part. On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding, of which 412,500 are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. All share and per share amounts have been retroactively restated to reflect the share dividend. The forfeiture amounts were determined such that the initial shareholders will collectively own 20% <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of the Company’s issued and outstanding ordinary shares after the <div style="letter-spacing: 0px; top: 0px;;display:inline;">IPO</div>. As of September 30, 2021, there were 3,162,500 Class B ordinary shares outstanding. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act (As Revised) of the Cayman Islands or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by the Company’s shareholders</div></div>. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-thirds</div> of the Company’s ordinary shares that are voted, and pursuant to the Company’s amended and restated memorandum and articles of association; such actions include amending the Company’s amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. The Company’s board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed in each year. There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment of directors can appoint all of the directors. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. The Company’s shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares and will automatically convert into Class A ordinary shares, which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions if <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>he Company does not consummate an initial Business Combination, at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20%<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of its management team upon conversion of Working Capital Loans and extension loans. Any conversion of Class B ordinary shares described herein will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less </div></div>than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one.</div></div> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public Warrants </div></div></div></div>– Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described adjacent to “Redemption of public warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than <span style="-sec-ix-hidden:hidden34616397">twenty</span> business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of public warrants</div></div></div></div>. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 1%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 1%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 1%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">upon a minimum of 30 days’ prior written notice of redemption, which the Company refer to as the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“30-day</div> redemption period”; and </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 1%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Redemption Procedures—Anti-dilution Adjustments”) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company send the notice of redemption to the warrant holders. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants —Public Shareholders’ Warrants—Redemption Procedures—Anti-dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company calls the Public Warrants for redemption as described above, it will have the option to require any holder that wishes to exercise its public warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their public warrants on a “cashless basis,” the Company will consider, among other factors, its cash position, the number of public warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of Class A ordinary shares issuable upon the exercise of the Public Warrants. If the Company takes advantage of this option, all holders of Public Warrants would pay the exercise price by surrendering their public warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-day</div> average closing price as of the date on which the notice of redemption is sent to the holders of the warrants. If the Company takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Class A ordinary shares to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. The Company believes this feature is an attractive option if it does not need the cash from the exercise of the warrants after the Business Combination. If the Company calls the warrants for redemption and does not take advantage of this option, the Sponsor and its permitted transferees would still be entitled to exercise their private placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if the Company is not the surviving company in the Business Combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants. </div></div>

5000000

0.0001

500000000

0.0001

50000000

0.0001

one

2875000

375000

1.1

3162500

412500

0.20

3162500

P3Y 1 0.50 0.20

one-to-one

11.50

9.20

0.60 P20D 9.20 1.15 18.00 1.80 P30D

P5Y

P60D P60D 0.01 P30D

18.00

P20D P30D P30D 18.00

11.50

P10D

<div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8 — Subsequent Events </div></div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. Based upon this evaluation, the Company did not identify any other subsequent events that would have required adjustments or disclosure in the financial statements, other than those disclosed below: </div></div></div> <div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December</div></div><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 14, 2021, Company’s commenced the IPO of 11,000,000 units (or 12,650,000 units if the underwriters’ over-allotment option is exercised in full) at $10.00 per unit. On December 15, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 12,650,000 and generated gross proceeds of $126,500,000. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the consummation of th<div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div> IPO, the Company consummated the private placement of 4,700,000 warrants (or 5,195,000 warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500. </div><br/></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the IPO, the Company entered into the following agreements: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">An Underwriting Agreement, dated December 9, 2021, between the Company, UBS Securities LLC and Kempen & Co. USA, Inc. (the “<div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Underwriting Agreement</div>”). </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Amended and Restated Memorandum and Articles of Association of the Company, dated December 9, 2021. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Warrant Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Letter Agreement, dated December 9, 2021, between the Company and its officers, directors and the Sponsor. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An Investment Management Trust Agreement, dated December 9, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Registration and Shareholder Rights Agreement, dated December 9, 2021, among the Company and the Sponsor. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An Administrative Services Agreement, dated December 9, 2021, between the Company and the Sponsor. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Private Placement Warrants Purchase Agreement, dated December 9, 2021, between the Company and the Sponsor. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Indemnity Agreements, each dated December 9, 2021, between the Company and each of its executive officers and directors. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Forward Purchase Agreement, dated December 9, 2021, between the Company and Forbion Growth Sponsor FEAC I B.V. </div></div></div> </td> </tr> </table>

1.1

3162500

11000000

12650000

10.00

12650000

126500000 4700000 5195000 1.50

7792500

This number includes up to 412,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Notes 5 and 8). On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend (see Note 8). The accompanying notes are an integral part of these unaudited condensed financial statements. This number excludes an aggregate of up to 412,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Notes 5 and 8). On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend (see Note 8). This number includes up to 412,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Notes 5 and 8). On December 9, 2021, the Company effected a stock dividend of 1.1 shares for each outstanding share, resulting in there being an aggregate of 3,162,500 Founder Shares outstanding. All share and per share amounts have been retroactively restated to reflect the share dividend (see Note 8).

EXCEL 37 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 38 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 97 262 1 true 43 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://for.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheet Sheet http://for.com/role/CondensedBalanceSheet Condensed Balance Sheet Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheet (Parenthetical) Sheet http://for.com/role/CondensedBalanceSheetParenthetical Condensed Balance Sheet (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements Of Operations Sheet http://for.com/role/CondensedStatementsOfOperations Condensed Statements Of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements Of Operations (Parenthetical) Sheet http://for.com/role/CondensedStatementsOfOperationsParenthetical Condensed Statements Of Operations (Parenthetical) Statements 5 false false R6.htm 1006 - Statement - Condensed Statement Of Changes In Shareholder's Equity Sheet http://for.com/role/CondensedStatementOfChangesInShareholderSEquity Condensed Statement Of Changes In Shareholder's Equity Statements 6 false false R7.htm 1007 - Statement - Condensed Statement Of Changes In Shareholder's Equity (Parenthetical) Sheet http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical Condensed Statement Of Changes In Shareholder's Equity (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Condensed Statement Of Cash Flows Sheet http://for.com/role/CondensedStatementOfCashFlows Condensed Statement Of Cash Flows Statements 8 false false R9.htm 1009 - Disclosure - Organization, Business Operation and Liquidity Sheet http://for.com/role/OrganizationBusinessOperationAndLiquidity Organization, Business Operation and Liquidity Notes 9 false false R10.htm 1010 - Disclosure - Significant Accounting Policies Sheet http://for.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 1011 - Disclosure - IPO Sheet http://for.com/role/Ipo IPO Notes 11 false false R12.htm 1012 - Disclosure - Private Placement Sheet http://for.com/role/PrivatePlacement Private Placement Notes 12 false false R13.htm 1013 - Disclosure - Related Party Transactions Sheet http://for.com/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 1014 - Disclosure - Commitments & Contingencies Sheet http://for.com/role/CommitmentsContingencies Commitments & Contingencies Notes 14 false false R15.htm 1015 - Disclosure - Shareholder's Equity Sheet http://for.com/role/ShareholderSEquity Shareholder's Equity Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://for.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://for.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://for.com/role/SignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Organization, Business Operation and Liquidity - Additional Information (Details) Sheet http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails Organization, Business Operation and Liquidity - Additional Information (Details) Details 18 false false R19.htm 1019 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 19 false false R20.htm 1020 - Disclosure - IPO - Additional Information (Details) Sheet http://for.com/role/IpoAdditionalInformationDetails IPO - Additional Information (Details) Details 20 false false R21.htm 1021 - Disclosure - Private Placement - Additional Information (Details) Sheet http://for.com/role/PrivatePlacementAdditionalInformationDetails Private Placement - Additional Information (Details) Details 21 false false R22.htm 1022 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 22 false false R23.htm 1023 - Disclosure - Commitments & Contingencies - Additional Information (Details) Sheet http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails Commitments & Contingencies - Additional Information (Details) Details 23 false false R24.htm 1024 - Disclosure - Shareholder's Equity - Additional Information (Details) Sheet http://for.com/role/ShareholderSEquityAdditionalInformationDetails Shareholder's Equity - Additional Information (Details) Details 24 false false R25.htm 1025 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://for.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 25 false false All Reports Book All Reports d250880d10q.htm d250880dex311.htm d250880dex312.htm d250880dex321.htm d250880dex322.htm frbn-20210930.xsd frbn-20210930_cal.xml frbn-20210930_def.xml frbn-20210930_lab.xml frbn-20210930_pre.xml http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 43 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d250880d10q.htm": { "axisCustom": 6, "axisStandard": 9, "contextCount": 97, "dts": { "calculationLink": { "local": [ "frbn-20210930_cal.xml" ] }, "definitionLink": { "local": [ "frbn-20210930_def.xml" ] }, "inline": { "local": [ "d250880d10q.htm" ] }, "labelLink": { "local": [ "frbn-20210930_lab.xml" ] }, "presentationLink": { "local": [ "frbn-20210930_pre.xml" ] }, "schema": { "local": [ "frbn-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 275, "entityCount": 1, "hidden": { "http://for.com/20210930": 1, "http://xbrl.sec.gov/dei/2021": 4, "total": 5 }, "keyCustom": 68, "keyStandard": 194, "memberCustom": 31, "memberStandard": 10, "nsprefix": "frbn", "nsuri": "http://for.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://for.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Significant Accounting Policies", "role": "http://for.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "frbn:DisclosureOfInitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - IPO", "role": "http://for.com/role/Ipo", "shortName": "IPO", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "frbn:DisclosureOfInitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "frbn:DisclosureOfPrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Private Placement", "role": "http://for.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "frbn:DisclosureOfPrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Related Party Transactions", "role": "http://for.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Commitments & Contingencies", "role": "http://for.com/role/CommitmentsContingencies", "shortName": "Commitments & Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Shareholder's Equity", "role": "http://for.com/role/ShareholderSEquity", "shortName": "Shareholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Subsequent Events", "role": "http://for.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://for.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Organization, Business Operation and Liquidity - Additional Information (Details)", "role": "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "shortName": "Organization, Business Operation and Liquidity - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityIncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "role": "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance Sheet", "role": "http://for.com/role/CondensedBalanceSheet", "shortName": "Condensed Balance Sheet", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommonStockConversionBasis", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - IPO - Additional Information (Details)", "role": "http://for.com/role/IpoAdditionalInformationDetails", "shortName": "IPO - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "frbn:DisclosureOfInitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn12_15_2021_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "2", "lang": null, "name": "frbn:PaymentsToAcquireRestrictedInvestmentsPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "frbn:DisclosureOfPrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P12_15_2021To12_15_2021_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "frbn:ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Private Placement - Additional Information (Details)", "role": "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "shortName": "Private Placement - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "frbn:DisclosureOfPrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P12_15_2021To12_15_2021_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "frbn:ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueIssuedForServices", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "lang": "en-US", "name": "frbn:BusinessCombinationConsummationPeriodExtensionTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn12_14_2021", "decimals": "4", "first": true, "lang": null, "name": "frbn:Underwritingcommissionperunit", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Commitments & Contingencies - Additional Information (Details)", "role": "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "shortName": "Commitments & Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn12_14_2021", "decimals": "4", "first": true, "lang": null, "name": "frbn:Underwritingcommissionperunit", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Shareholder's Equity - Additional Information (Details)", "role": "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "shortName": "Shareholder's Equity - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P12_09_2021To12_09_2021", "decimals": null, "lang": "en-US", "name": "frbn:BoardOfDirectorsServiceTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Subsequent Events - Additional Information (Details)", "role": "http://for.com/role/SubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P12_14_2021To12_14_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantMemberusgaapStatementClassOfStockAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "0", "lang": null, "name": "frbn:ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance Sheet (Parenthetical)", "role": "http://for.com/role/CondensedBalanceSheetParenthetical", "shortName": "Condensed Balance Sheet (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "frbn:FormationCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statements Of Operations", "role": "http://for.com/role/CondensedStatementsOfOperations", "shortName": "Condensed Statements Of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "frbn:FormationCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statements Of Operations (Parenthetical)", "role": "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "shortName": "Condensed Statements Of Operations (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn08_08_2021", "decimals": null, "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statement Of Changes In Shareholder's Equity", "role": "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "shortName": "Condensed Statement Of Changes In Shareholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn08_08_2021", "decimals": null, "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "PAsOn09_30_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Condensed Statement Of Changes In Shareholder's Equity (Parenthetical)", "role": "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "shortName": "Condensed Statement Of Changes In Shareholder's Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Condensed Statement Of Cash Flows", "role": "http://for.com/role/CondensedStatementOfCashFlows", "shortName": "Condensed Statement Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": "0", "lang": null, "name": "frbn:FormationCostPaidBySponsor", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Organization, Business Operation and Liquidity", "role": "http://for.com/role/OrganizationBusinessOperationAndLiquidity", "shortName": "Organization, Business Operation and Liquidity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d250880d10q.htm", "contextRef": "P08_09_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 43, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Entity Incorporation Date Of Incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "frbn_AccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting policies.", "label": "Accounting Policies [Line Items]" } } }, "localname": "AccountingPoliciesLineItems", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_AccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting policies.", "label": "Accounting Policies [Table]" } } }, "localname": "AccountingPoliciesTable", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_AccruedOfferingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued offering costs and expenses.", "label": "Accrued Offering Costs and Expenses", "terseLabel": "Accrued offering costs and expenses" } } }, "localname": "AccruedOfferingCostsAndExpenses", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "frbn_AdditionalDepositInAdvanceFromRelatedPartyDepositedInRestrictedInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional deposit in advance from related party deposited in restricted investments.", "label": "Additional Deposit In Advance From Related Party Deposited In Restricted Investments", "terseLabel": "Additional Deposit In advance From Related Party Deposited In Restricted Investments" } } }, "localname": "AdditionalDepositInAdvanceFromRelatedPartyDepositedInRestrictedInvestments", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_AdditionalForwardPurchaseSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Forward Purchase Shares [Member]", "label": "Additional Forward Purchase Shares [Member]" } } }, "localname": "AdditionalForwardPurchaseSharesMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_AdditionalTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional transaction costs.", "label": "Additional Transaction Costs", "terseLabel": "Additional transaction costs" } } }, "localname": "AdditionalTransactionCosts", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_AdvanceFromTheSponsorDepositedInTrustAccount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advance from the sponsor deposited in trust account.", "label": "Advance From The Sponsor Deposited In Trust Account", "terseLabel": "Advance from the sponsor deposited in trust account" } } }, "localname": "AdvanceFromTheSponsorDepositedInTrustAccount", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_AggregateTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate transaction costs.", "label": "Aggregate Transaction Costs", "terseLabel": "Aggregate Transaction Costs" } } }, "localname": "AggregateTransactionCosts", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_AgreementaxisAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AgreementAxis", "label": "AgreementAxis [Axis]" } } }, "localname": "AgreementaxisAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_BasisAxisAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis Axis", "label": "Basis Axis [Axis]" } } }, "localname": "BasisAxisAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_BasisDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis", "label": "Basis [Domain]" } } }, "localname": "BasisDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_BoardOfDirectorsServiceTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board of directors service term.", "label": "Board Of Directors Service Term", "terseLabel": "Board of directors, Service term" } } }, "localname": "BoardOfDirectorsServiceTerm", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_BusinessCombinationConsummationPeriodExtensionTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination Consummation Period Extension Terms.", "label": "Business Combination Consummation Period Extension Terms", "terseLabel": "Business combination, Consummation period, Extension terms" } } }, "localname": "BusinessCombinationConsummationPeriodExtensionTerms", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_CashDepositedInTrustAccountPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash deposited in trust account per unit.", "label": "Cash Deposited In Trust Account Per Unit", "terseLabel": "Cash deposited in Trust Account per Unit" } } }, "localname": "CashDepositedInTrustAccountPerUnit", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_ClassOfWarrantOrRightIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right issued during the period.", "label": "Class Of Warrant Or Right Issued During The Period", "terseLabel": "Class of warrants or rights warrants issued during the period" } } }, "localname": "ClassOfWarrantOrRightIssuedDuringThePeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_ClassOfWarrantOrRightRedemptionPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Redemption Price Per Warrant.", "label": "Class Of Warrant Or Right Redemption Price Per Warrant", "terseLabel": "Class of warrant or right, Redemption price per warrant" } } }, "localname": "ClassOfWarrantOrRightRedemptionPricePerWarrant", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_ClassOfWarrantsExercisePriceAdjustmentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants, exercise price adjustment percentage.", "label": "Class Of Warrants Exercise Price Adjustment Percentage", "terseLabel": "Class of Warrants Exercise Price Adjustment Percentage" } } }, "localname": "ClassOfWarrantsExercisePriceAdjustmentPercentage", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issued during period warrants.", "label": "Class Of Warrants Or Rights Issued During Period Warrants", "terseLabel": "Class of warrants or rights issued during period, Warrants", "verboseLabel": "Class of warrants or rights issued during period, Warrants" } } }, "localname": "ClassOfWarrantsOrRightsIssuedDuringPeriodWarrants", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_ClassOfWarrantsOrRightsWarrantsIssuedIssuePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights warrants issued issue price.", "label": "Class Of Warrants Or Rights Warrants Issued Issue Price", "terseLabel": "Class of warrants or rights warrants issued issue price per warrant" } } }, "localname": "ClassOfWarrantsOrRightsWarrantsIssuedIssuePrice", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_CommonSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Common shares subject to forfeiture", "documentation": "Common shares subject to forfeiture.", "label": "Common shares subject to forfeiture", "terseLabel": "Common shares subject to forfeiture", "verboseLabel": "Common shares subject to forfeiture" } } }, "localname": "CommonSharesSubjectToForfeiture", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "frbn_CommonStockThresholdPercentageOnConversionOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock threshold percentage on conversion of shares.", "label": "Common stock threshold percentage on conversion of shares", "terseLabel": "Common stock, threshold percentage on conversion of shares" } } }, "localname": "CommonStockThresholdPercentageOnConversionOfShares", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_DeferredOfferingCostsIncludedInAccruedOfferingsCostsAndExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in accrued offerings costs and expenses", "label": "Deferred Offering Costs Included In Accrued Offerings Costs And Expenses", "verboseLabel": "Deferred offering costs included in accrued offerings costs and expenses" } } }, "localname": "DeferredOfferingCostsIncludedInAccruedOfferingsCostsAndExpenses", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "frbn_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares.", "label": "Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares", "verboseLabel": "Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares" } } }, "localname": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "frbn_DeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions.", "label": "Deferred Underwriting Commissions", "terseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_DisclosureOfInitialPublicOfferingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of initial public offering.", "label": "Disclosure Of Initial Public Offering [Line Items]" } } }, "localname": "DisclosureOfInitialPublicOfferingLineItems", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_DisclosureOfInitialPublicOfferingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of initial public offering.", "label": "Disclosure Of Initial Public Offering [Table]" } } }, "localname": "DisclosureOfInitialPublicOfferingTable", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_DisclosureOfInitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of initial public offering.", "label": "Disclosure Of Initial Public Offering [Text Block]", "terseLabel": "IPO" } } }, "localname": "DisclosureOfInitialPublicOfferingTextBlock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/Ipo" ], "xbrltype": "textBlockItemType" }, "frbn_DisclosureOfPrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Private Placement.", "label": "Disclosure Of Private Placement [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "DisclosureOfPrivatePlacementTextBlock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "frbn_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "frbn_EventBasisAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event Basis [Axis]", "label": "Event Basis [Axis]" } } }, "localname": "EventBasisAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_EventBasisDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event Basis [Domain]", "label": "Event Basis [Domain]" } } }, "localname": "EventBasisDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_ExtendedPeriodWithinWhichBusinessCombinationShallBeConsummated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extended Period Within Which Business Combination Shall Be Consummated.", "label": "Extended Period Within Which Business Combination Shall Be Consummated", "terseLabel": "Extended period within which business combination shall be consummated" } } }, "localname": "ExtendedPeriodWithinWhichBusinessCombinationShallBeConsummated", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_ExtensionLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension Loans [Member]", "label": "Extension Loans [Member]", "terseLabel": "Extension Loans [Member]" } } }, "localname": "ExtensionLoansMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair market value as percentage of net assets held in trust account included in initial business combination.", "label": "Fair Market Value As Percentage Of Net Assets Held In Trust Account Included In Initial Business Combination", "terseLabel": "Fair market value as percentage of net assets held in trust account included in initial business combination" } } }, "localname": "FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_FirmForwardPurchaseSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Firm Forward Purchase Shares [Member]", "label": "Firm Forward Purchase Shares [Member]", "terseLabel": "Firm Forward Purchase Shares [Member]" } } }, "localname": "FirmForwardPurchaseSharesMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_ForbionEuropeanSponsorLLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forbion European Sponsor LLP [Member]", "label": "Forbion European Sponsor LLP [Member]" } } }, "localname": "ForbionEuropeanSponsorLLPMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_FormationCost": { "auth_ref": [], "calculation": { "http://for.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Formation cost.", "label": "Formation cost", "terseLabel": "Formation costs" } } }, "localname": "FormationCost", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "frbn_FormationCostPaidBySponsor": { "auth_ref": [], "calculation": { "http://for.com/role/CondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Formation cost paid by sponsor.", "label": "Formation cost paid by Sponsor", "verboseLabel": "Formation cost paid by Sponsor" } } }, "localname": "FormationCostPaidBySponsor", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "frbn_ForwardPurchaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forward Purchase Agreements [Member]", "label": "Forward Purchase Agreements [Member]" } } }, "localname": "ForwardPurchaseAgreementsMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder Shares [Member]", "label": "Founder Shares [Member]", "terseLabel": "Founder shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_FpaPurchaserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "FPA Purchaser", "label": "FPA Purchaser [Member]" } } }, "localname": "FpaPurchaserMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_IPOAndOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IPO And Over Allotment Option [Member]", "label": "IPO And Over Allotment Option [Member]", "terseLabel": "IPO And Over Allotment Option [Member]" } } }, "localname": "IPOAndOverAllotmentOptionMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_IPOAndPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IPO And Private Placement [Member]", "label": "IPO And Private Placement [Member]", "terseLabel": "IPO And Private Placement [Member]" } } }, "localname": "IPOAndPrivatePlacementMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_InorderToExtendConsummationPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inorder To Extend Consummation Period [Member]", "label": "Inorder To Extend Consummation Period [Member]" } } }, "localname": "InorderToExtendConsummationPeriodMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_InvestorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor [Axis]", "label": "Investor [Axis]" } } }, "localname": "InvestorAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_InvestorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investor", "label": "Investor [Domain]" } } }, "localname": "InvestorDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_LockUpPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock Up Period.", "label": "Lock Up Period", "terseLabel": "Lock up period" } } }, "localname": "LockUpPeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "frbn_MinimumNoticeOfRedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum notice of redemption period.", "label": "Minimum Notice Of Redemption Period", "terseLabel": "Minimum notice of redemption period" } } }, "localname": "MinimumNoticeOfRedemptionPeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_MinimumPerShareAmountToBeMaintainedInTheTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum per share amount to be maintained in the trust account.", "label": "Minimum Per Share Amount To Be Maintained In The Trust Account" } } }, "localname": "MinimumPerShareAmountToBeMaintainedInTheTrustAccount", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_NumberOfClassOfDirectorsBeingAppointedInEachYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of class of directors being appointed in each year.", "label": "Number of class of directors being appointed in each year", "terseLabel": "Number of class of directors being appointed in each year" } } }, "localname": "NumberOfClassOfDirectorsBeingAppointedInEachYear", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "frbn_NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days after consummation of business combination within which securities registration shall be effective.", "label": "Number Of Days After Consummation Of Business Combination Within Which Securities Registration Shall be Effective", "terseLabel": "Number of days after consummation of business combination within which securities registration shall be effective" } } }, "localname": "NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_NumberOfDaysOfAverageClosingPriceDeterminingFairMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Days of Average Closing Price determining Fair Market Value.", "label": "Number Of Days Of Average Closing Price determining Fair Market Value", "terseLabel": "Number Of Days Of Average Closing Price determining Fair Market Value" } } }, "localname": "NumberOfDaysOfAverageClosingPriceDeterminingFairMarketValue", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_NumberOfTradingDaysDeterminingVolumeWeightedAverageTradingPriceOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days determining volume weighted average trading price of common stock.", "label": "Number of Trading Days Determining Volume Weighted Average Trading Price of Common Stock", "terseLabel": "Number of trading days determining volume weighted average trading price of common stock" } } }, "localname": "NumberOfTradingDaysDeterminingVolumeWeightedAverageTradingPriceOfCommonStock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_Numberofagreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Agreements.", "label": "NumberOfAgreements", "verboseLabel": "Number of agreements" } } }, "localname": "Numberofagreements", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "frbn_Numberofconsecutivetradingdaysdeterminingshareprice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Consecutive Trading Days Determining Share Price", "label": "NumberOfConsecutiveTradingDaysDeterminingSharePrice", "terseLabel": "Number of consecutive trading days determining share price", "verboseLabel": "Number of consecutive trading days determining share price" } } }, "localname": "Numberofconsecutivetradingdaysdeterminingshareprice", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_Numberofdemandsthatcanbemade": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Demands That Can Be Made.", "label": "NumberOfDemandsThatCanBeMade", "verboseLabel": "Number of demands that can be made" } } }, "localname": "Numberofdemandsthatcanbemade", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "frbn_Numberofindividualsforappointmenttotheboardofdirectorsnominatedbysponsor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Individuals For Appointment To The Board Of Directors Nominated By Sponsor", "label": "NumberOfIndividualsForAppointmentToTheBoardOfDirectorsNominatedBySponsor", "verboseLabel": "Number of individuals for appointment to the board of directors nominated by sponsor" } } }, "localname": "Numberofindividualsforappointmenttotheboardofdirectorsnominatedbysponsor", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "frbn_Numberoftradingdaysdeterminingshareprice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Trading Days Determining Share Price", "label": "NumberOfTradingDaysDeterminingSharePrice", "terseLabel": "Number of trading days determining share price", "verboseLabel": "Number of trading days determining share price" } } }, "localname": "Numberoftradingdaysdeterminingshareprice", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs associated with initial public offering.", "label": "Offering Costs Associated With Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs associated with the IPO" } } }, "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "frbn_OfficeSpaceSecretarialAndAdministrativeServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Space Secretarial And Administrative Services [Member]", "label": "Office Space Secretarial And Administrative Services [Member]", "terseLabel": "Office Space Secretarial And Administrative Services [Member]" } } }, "localname": "OfficeSpaceSecretarialAndAdministrativeServicesMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_OptionVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Vesting Period.", "label": "Option Vesting Period", "verboseLabel": "Option vesting period" } } }, "localname": "OptionVestingPeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other Offering Costs", "terseLabel": "Other Offering Costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments to acquire restricted investment for each additional three month period.", "label": "Payments To Acquire Restricted Investment For Each Additional Three Month Period", "terseLabel": "Payments to acquire restricted investment for each additional three month period" } } }, "localname": "PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriodPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payments to acquire restricted investment for each additional three month period per share.", "label": "Payments To Acquire Restricted Investment For Each Additional Three Month Period Per Share", "terseLabel": "Payments to acquire restricted investment for each additional three month period, Per share" } } }, "localname": "PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriodPerShare", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_PaymentsToAcquireRestrictedInvestmentsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payments to acquire restricted investments per unit.", "label": "Payments To Acquire Restricted Investments Per Unit", "terseLabel": "Payments to acquire restricted investment, Per unit" } } }, "localname": "PaymentsToAcquireRestrictedInvestmentsPerUnit", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_Paymentstoacquirerestrictedinvestmentforeachadditionalthreemonthperiodpershare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriodPerShare", "label": "PaymentsToAcquireRestrictedInvestmentForEachAdditionalThreeMonthPeriodPerShare", "verboseLabel": "Payments to acquire restricted investment for each additional three month period, Per share" } } }, "localname": "Paymentstoacquirerestrictedinvestmentforeachadditionalthreemonthperiodpershare", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PercentageHoldingOfCommonStockEligibleForVotingOfDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage holding of common stock eligible for voting of directors.", "label": "Percentage holding of common stock eligible for voting of directors", "terseLabel": "Percentage holding of common stock eligible for voting of directors" } } }, "localname": "PercentageHoldingOfCommonStockEligibleForVotingOfDirectors", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PercentageOfDutchDividendWithholdingTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of dutch dividend withholding tax.", "label": "Percentage Of Dutch Dividend Withholding Tax", "terseLabel": "Percentage of dutch dividend withholding tax" } } }, "localname": "PercentageOfDutchDividendWithholdingTax", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PercentageOfOutstandingPrivatePlacementWarrantHeldByHoldersWhoVoteInAmendingTermsOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding private placement warrant held by holders who vote in amending terms of warrant.", "label": "Percentage Of Outstanding Private Placement Warrant Held By Holders Who Vote In Amending Terms Of Warrant", "terseLabel": "Percentage of outstanding private placement warrant held by holders who vote in amending terms of warrant" } } }, "localname": "PercentageOfOutstandingPrivatePlacementWarrantHeldByHoldersWhoVoteInAmendingTermsOfWarrant", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PercentageOfOwnershipHeldByInitialShareholdersAfterThePublicOffer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of ownership held by initial shareholders after the public offer.", "label": "Percentage Of Ownership Held By Initial Shareholders After The Public Offer", "terseLabel": "Percentage of ownership held by initial shareholders after the Public Offer" } } }, "localname": "PercentageOfOwnershipHeldByInitialShareholdersAfterThePublicOffer", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PercentageOfPublicSharesToBeRedeemedInCaseDoesNotInitialBusinessCombinationWithinCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of public shares to be redeemed in case does not initial business combination within combination period.", "label": "Percentage Of Public Shares To Be Redeemed In Case Does Not Initial Business Combination Within Combination Period", "terseLabel": "Percentage of public shares to be redeemed in case does not complete initial business combination within combination period" } } }, "localname": "PercentageOfPublicSharesToBeRedeemedInCaseDoesNotInitialBusinessCombinationWithinCombinationPeriod", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PeriodAfterWhichTheWarrantsAreExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period after which the warrants are exercisable.", "label": "Period After Which The Warrants Are Exercisable", "terseLabel": "Period after which the warrants are exercisable" } } }, "localname": "PeriodAfterWhichTheWarrantsAreExercisable", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_PeriodToCompleteBusinessCombinationFromClosingOfTheInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period to complete business combination from closing of the initial public offering.", "label": "Period To Complete Business Combination From Closing of the Initial Public Offering", "terseLabel": "Period To complete business combination from closing of the Initial Public Offering" } } }, "localname": "PeriodToCompleteBusinessCombinationFromClosingOfTheInitialPublicOffering", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_PostTransactionOwnershipPercentageOfTheTargetEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post transaction ownership percentage of the target entity.", "label": "Post Transaction Ownership Percentage Of The Target Entity", "terseLabel": "Post-transaction ownership percentage of the target entity" } } }, "localname": "PostTransactionOwnershipPercentageOfTheTargetEntity", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Abstract.", "label": "Private Placement [Abstract]" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://for.com/20210930", "xbrltype": "stringItemType" }, "frbn_PrivatePlacementAndOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement And Over Allotment Option [Member]", "label": "Private Placement And Over Allotment Option [Member]", "terseLabel": "Private Placement And Over Allotment Option [Member]" } } }, "localname": "PrivatePlacementAndOverAllotmentOptionMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement", "label": "Private Placement [Line Items]" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant [Member]", "label": "Private Placement Warrant [Member]", "terseLabel": "Private Placement Warrant [Member]" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from equity used for funding business combination as a percentage of the total.", "label": "Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total", "terseLabel": "Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total" } } }, "localname": "ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_ProceedsFromIssuanceInitialPublicOfferingAndOverAllotmentOptionGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance initial public offering and over allotment option gross.", "label": "Proceeds From Issuance Initial Public Offering And Over Allotment Option Gross", "terseLabel": "Proceeds from issuance initial public offering and over allotment option, Gross", "verboseLabel": "Proceeds from issuance initial public offering and over allotment option, Gross" } } }, "localname": "ProceedsFromIssuanceInitialPublicOfferingAndOverAllotmentOptionGross", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrant.", "label": "Public Warrant [Member]", "terseLabel": "Public Warrant [Member]" } } }, "localname": "PublicWarrantMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrants.", "label": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_RedeemableWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable Warrants.", "label": "Redeemable Warrants [Member]" } } }, "localname": "RedeemableWarrantsMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "frbn_RedemptionTriggerPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption trigger price per share.", "label": "Redemption Trigger Price Per Share", "terseLabel": "Redemption trigger price per share" } } }, "localname": "RedemptionTriggerPricePerShare", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_RedemptionValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption value per share.", "label": "Redemption Value Per Share" } } }, "localname": "RedemptionValuePerShare", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_RegistrationAndShareholderRightsAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Registration And Shareholder Rights Agreement [Member]", "label": "Registration And Shareholder Rights Agreement [Member]", "terseLabel": "Registration And Shareholder Rights Agreement [Member]" } } }, "localname": "RegistrationAndShareholderRightsAgreementMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_RestrictionOnTransferOfFounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restriction On Transfer Of Founder Shares [Member]", "label": "Restriction On Transfer Of Founder Shares [Member]", "terseLabel": "Restriction On Transfer Of Founder Shares [Member]" } } }, "localname": "RestrictionOnTransferOfFounderSharesMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SalaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salary", "label": "Salary [Member]", "terseLabel": "Salary [Member]" } } }, "localname": "SalaryMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceAtEighteenUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price At Eighteen USD [Member].", "label": "Share Price At Eighteen USD [Member]", "terseLabel": "Share Price At Eighteen USD [Member]" } } }, "localname": "SharePriceAtEighteenUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceBelowEighteenUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Below Eighteen USD [Member].", "label": "Share Price Below Eighteen USD [Member]", "terseLabel": "Share Price Below Eighteen USD [Member]" } } }, "localname": "SharePriceBelowEighteenUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceEqualsOrExceedsEighteenUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Equals Or Exceeds Eighteen USD [Member].", "label": "Share Price Equals Or Exceeds Eighteen USD [Member]" } } }, "localname": "SharePriceEqualsOrExceedsEighteenUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceEqualsOrExceedsTwelveUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Equals Or Exceeds Twelve USD [Member]", "label": "Share Price Equals Or Exceeds Twelve USD [Member]", "terseLabel": "Share Price Equals Or Exceeds Twelve USD [Member]" } } }, "localname": "SharePriceEqualsOrExceedsTwelveUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceLessThanNinePointTwentyUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price less than nine point twenty USD [Member].", "label": "Share Price Less Than Nine Point Twenty USD [Member]", "terseLabel": "Share Price Less Than Nine Point Twenty USD [Member]" } } }, "localname": "SharePriceLessThanNinePointTwentyUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SharePriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Range [Axis]" } } }, "localname": "SharePriceRangeAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_SharePriceRangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Range [Domain]" } } }, "localname": "SharePriceRangeDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor.", "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_StockDividendForEachOutstandingShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Dividend For Each Outstanding Share [Member]", "label": "Stock Dividend For Each Outstanding Share [Member]" } } }, "localname": "StockDividendForEachOutstandingShareMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_StockDividendPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock dividend per share.", "label": "Stock Dividend Per Share", "terseLabel": "Stock dividend, Per share", "verboseLabel": "Stock dividend, Per share" } } }, "localname": "StockDividendPerShare", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity policy.", "label": "Temporary Equity Policy [Policy Text Block]", "terseLabel": "Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "frbn_TermOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of restricted investments.", "label": "Term Of Restricted Investments", "terseLabel": "Term of restricted investments" } } }, "localname": "TermOfRestrictedInvestments", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_ThresholdPeriodFromTheClosingOfThePublicOfferingExtendsThePeriodOfTimeToConsummateABusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period from the closing of the public offering extends the period of time to consummate a business combination.", "label": "Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination", "terseLabel": "Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination" } } }, "localname": "ThresholdPeriodFromTheClosingOfThePublicOfferingExtendsThePeriodOfTimeToConsummateABusinessCombination", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_ThresholdPeriodFromTheClosingOfThePublicOfferingToConsummateABusinessCombinationAsPerAmendedAndRestatedMemorandumAndArticlesOfAssociation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period from the closing of the public offering to consummate a business combination as per amended and restated memorandum and articles of association.", "label": "Threshold Period From The Closing Of The Public Offering To Consummate A Business Combination As Per Amended And Restated Memorandum and Articles Of Association", "terseLabel": "Threshold period from the closing of public offering to consummate business combination as per amended and restated and restated articles of association" } } }, "localname": "ThresholdPeriodFromTheClosingOfThePublicOfferingToConsummateABusinessCombinationAsPerAmendedAndRestatedMemorandumAndArticlesOfAssociation", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_Thresholdnumberoftradingdaysdeterminingshareprice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold Number Of Trading Days Determining Share Price", "label": "ThresholdNumberOfTradingDaysDeterminingSharePrice", "terseLabel": "Threshold number of trading days determining share price" } } }, "localname": "Thresholdnumberoftradingdaysdeterminingshareprice", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "frbn_TotalOfferingCostsAssociatedWithInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total offering costs associated with initial public offering.", "label": "Total Offering Costs Associated With Initial Public Offering", "terseLabel": "Offering costs" } } }, "localname": "TotalOfferingCostsAssociatedWithInitialPublicOffering", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_TransferBetweenForbionEuropeanSponsorLLPAndSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer Between Forbion European Sponsor LLP And Sponsor [Member]", "label": "Transfer Between Forbion European Sponsor LLP And Sponsor [Member]", "terseLabel": "Transfer Between Forbion European Sponsor LLP And Sponsor [Member]" } } }, "localname": "TransferBetweenForbionEuropeanSponsorLLPAndSponsorMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting Agreement [Member]", "label": "Underwriting Agreement [Member]", "terseLabel": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_UnderwritingCommissions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriting commissions.", "label": "Underwriting Commissions", "terseLabel": "Underwriting commissions" } } }, "localname": "UnderwritingCommissions", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "frbn_Underwritingcommissionperunit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting Commission Per Unit", "label": "UnderwritingCommissionPerUnit", "verboseLabel": "Underwriting commission, Per unit" } } }, "localname": "Underwritingcommissionperunit", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "frbn_UnitNumberOfSharesIncludedInUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unit number of shares included in unit.", "label": "Unit Number Of Shares Included In Unit", "terseLabel": "Number of shares included in Unit" } } }, "localname": "UnitNumberOfSharesIncludedInUnit", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_VolumeWeightedAverageTradingPriceBelowNinePointTwentyUsdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume weighted average trading price below nine point twenty USD [Member].", "label": "Volume Weighted Average Trading Price Below Nine Point Twenty USD [Member]" } } }, "localname": "VolumeWeightedAverageTradingPriceBelowNinePointTwentyUsdMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_VolumeWeightedAverageTradingPriceOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume weighted average trading price of common stock.", "label": "Volume Weighted Average Trading Price of Common stock", "terseLabel": "Volume weighted average trading price of common stock" } } }, "localname": "VolumeWeightedAverageTradingPriceOfCommonStock", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "frbn_VolumeWeightedAverageTradingPriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Trading Price Range [Axis]" } } }, "localname": "VolumeWeightedAverageTradingPriceRangeAxis", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "frbn_VolumeWeightedAverageTradingPriceRangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volume Weighted Average Trading Price Range [Domain]" } } }, "localname": "VolumeWeightedAverageTradingPriceRangeDomain", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "frbn_WarrantsIssuedPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued price per warrant.", "label": "Warrants Issued Price Per Warrant", "terseLabel": "Warrants issued, Price per warrant" } } }, "localname": "WarrantsIssuedPricePerWarrant", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "frbn_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working Capital Loans [Member]", "label": "Working Capital Loans [Member]", "terseLabel": "Working Capital Loans [Member]" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://for.com/20210930", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r107", "r115", "r135", "r136", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r217", "r218", "r232", "r233" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r107", "r115", "r133", "r135", "r136", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r217", "r218", "r232", "r233" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r107", "r115", "r133", "r135", "r136", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r217", "r218", "r232", "r233" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r141", "r183" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r40", "r41", "r42", "r138", "r139", "r140", "r157" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r38", "r77", "r79", "r82", "r85", "r94", "r95", "r96", "r97", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r153", "r155", "r162", "r181", "r183", "r207", "r212" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_BankOverdrafts": { "auth_ref": [ "r14", "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.", "label": "Bank Overdrafts" } } }, "localname": "BankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r13", "r183", "r224", "r225" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r13", "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, August 9, 2021 (inception)" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.", "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r28", "r163" ], "calculation": { "http://for.com/role/CondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents at carrying value" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash insrued with federal deposit insurance corporation" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r36", "r38", "r54", "r55", "r56", "r58", "r60", "r64", "r65", "r66", "r85", "r94", "r98", "r99", "r100", "r103", "r104", "r113", "r114", "r117", "r121", "r162", "r239" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperations", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r131", "r137" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "presentationGuidance": "Exercise price of warrant", "terseLabel": "Class of warrant or right, Exercise price of warrants or rights", "verboseLabel": "Class of warrant or right, Exercise price of warrants or rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "presentationGuidance": "Number of shares issued upon exercise of warrant", "terseLabel": "Class of warrant or right, Number of securities called by each warrant or right", "verboseLabel": "Class of warrant or right, Number of securities called by each warrant or right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r16", "r91", "r209", "r215" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r88", "r89", "r90", "r92", "r231" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments & Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperations", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Common stock, Conversion basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "terseLabel": "Common stock, other shares, outstanding" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockOtherValueOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Value, Outstanding", "terseLabel": "Common stock, Other value, Outstanding" } } }, "localname": "CommonStockOtherValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share", "verboseLabel": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, Shares, Issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r127" ], "lang": { "en-us": { "role": { "definitionGuidance": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "positiveLabel": "Common stock, Shares, Outstanding", "terseLabel": "Common stock, Shares, Outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common stock, shares subscribed but unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscriptions": { "auth_ref": [ "r7", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Value, Subscriptions", "terseLabel": "Common stock, value, subscriptions" } } }, "localname": "CommonStockSharesSubscriptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r183" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Common stock, Voting rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r70", "r211" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r108" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r106", "r109" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r105", "r110", "r111", "r171", "r172", "r173" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "verboseLabel": "Deferred compensation liability, Noncurrent" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r18", "r87" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "verboseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.", "label": "Dividends [Axis]" } } }, "localname": "DividendsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.", "label": "Dividends [Domain]" } } }, "localname": "DividendsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r61", "r62" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r22", "r23", "r24", "r40", "r41", "r42", "r44", "r49", "r51", "r63", "r86", "r127", "r129", "r138", "r139", "r140", "r151", "r152", "r157", "r164", "r165", "r166", "r167", "r168", "r169", "r219", "r220", "r221", "r242" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r160", "r161" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r21", "r143", "r144", "r147", "r148", "r149", "r150" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r31" ], "calculation": { "http://for.com/role/CondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r38", "r85", "r162", "r183", "r208", "r214" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholder's Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "Liabilities and Shareholder's Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r15", "r38", "r85", "r94", "r95", "r96", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r154", "r155", "r156", "r162", "r181", "r182", "r183" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": { "auth_ref": [ "r2" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.", "label": "Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities", "terseLabel": "Expenses payable on liquidation" } } }, "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r227", "r228", "r229", "r230" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Banking Regulation, Mortgage Banking, Net Worth, Minimum", "terseLabel": "Minimum netorth needed to consummate business combination" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r67", "r76" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization, Business Operation and Liquidity" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidity" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r28", "r30", "r32" ], "calculation": { "http://for.com/role/CondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r19", "r20", "r24", "r25", "r32", "r38", "r43", "r45", "r46", "r47", "r48", "r50", "r51", "r57", "r77", "r78", "r80", "r81", "r83", "r85", "r94", "r95", "r96", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r158", "r162", "r210", "r216" ], "calculation": { "http://for.com/role/CondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://for.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfCashFlows", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "terseLabel": "Payments for underwriting expense" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "terseLabel": "Payments to acquire restricted investment", "verboseLabel": "Investment of cash in Trust Account" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r113" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r6", "r113" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r183" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from issuance initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "presentationGuidance": "Proceeds from private placement of warrants", "terseLabel": "Proceeds from issuance of warrants", "verboseLabel": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r134", "r176", "r177" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r176", "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "verboseLabel": "Related party transaction, Amounts of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r134", "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r134", "r176", "r178", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r174", "r175", "r177", "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r129", "r141", "r183", "r213", "r222", "r223" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r40", "r41", "r42", "r44", "r49", "r51", "r86", "r138", "r139", "r140", "r151", "r152", "r157", "r219", "r221" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "verboseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "presentationGuidance": "Shares issued price per share", "terseLabel": "Shares issued, Price per share", "verboseLabel": "Shares issued, Price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r35", "r39" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r5", "r6", "r7", "r36", "r38", "r54", "r55", "r56", "r58", "r60", "r64", "r65", "r66", "r85", "r94", "r98", "r99", "r100", "r103", "r104", "r113", "r114", "r117", "r121", "r127", "r162", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperations", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r17", "r22", "r23", "r24", "r40", "r41", "r42", "r44", "r49", "r51", "r63", "r86", "r127", "r129", "r138", "r139", "r140", "r151", "r152", "r157", "r164", "r165", "r166", "r167", "r168", "r169", "r219", "r220", "r221", "r242" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/CoverPage", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperations", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r40", "r41", "r42", "r63", "r194" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperations", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock issued during period, Shares, Issued for services", "verboseLabel": "Class B ordinary shares issued to Sponsor, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r127", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "presentationGuidance": "Stock issued during period shares new issues", "terseLabel": "Stock issued during period, Shares", "verboseLabel": "Stock issued during period, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Stock issued during period, Value, Issued for services", "verboseLabel": "Class B ordinary shares issued to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r38", "r84", "r85", "r162", "r183" ], "calculation": { "http://for.com/role/CondensedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total shareholder's equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Shareholder's Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r37", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r129", "r132" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholder's Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/ShareholderSEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplit": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "definitionGuidance": "Stockholders' Equity Note, Stock Split", "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.", "label": "Stockholders' Equity Note, Stock Split", "verboseLabel": "Stockholders' equity note, stock split" } } }, "localname": "StockholdersEquityNoteStockSplit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r170", "r185" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]", "verboseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r170", "r185" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r170", "r185" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r184", "r186" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CommitmentsContingenciesAdditionalInformationDetails", "http://for.com/role/CondensedBalanceSheetParenthetical", "http://for.com/role/CondensedStatementOfChangesInShareholderSEquityParenthetical", "http://for.com/role/CondensedStatementsOfOperationsParenthetical", "http://for.com/role/IpoAdditionalInformationDetails", "http://for.com/role/OrganizationBusinessOperationAndLiquidityAdditionalInformationDetails", "http://for.com/role/PrivatePlacementAdditionalInformationDetails", "http://for.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://for.com/role/ShareholderSEquityAdditionalInformationDetails", "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://for.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Number of Ordinary shares subject to possible redemptions" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r142", "r146" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued amounts for interest and penalties for unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r68", "r69", "r71", "r72", "r73", "r74", "r75" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants and rights outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/ShareholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r53", "r60" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Dilutive securities" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted weighted average Class B ordinary shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/CondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation", "terseLabel": "Weighted average number of shares common stock subject to repurchase or cancellation" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://for.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=95464943&loc=SL35686261-199414" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r234": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r235": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r236": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r237": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r238": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r239": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r240": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r241": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r39": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" } }, "version": "2.1" } ZIP 44 0001193125-22-015993-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-015993-xbrl.zip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